Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk

Critical Reviews in Toxicology

Volumn 26, Issue 4, 1996, Pages 365-481

  Huber, Wolfgang W ^a,b   Grasl Kraupp, Bettina ^a   Schulte Hermann, Rolf ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

hemodialysis; hepatocarcinogenesis; peroxisome proliferation; phthalates; risk evaluation

Indexed keywords

PEROXISOME PROLIFERATOR; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

CANCER RISK; CARCINOGENICITY; ENVIRONMENTAL EXPOSURE; ENZYME INDUCTION; HEMODIALYSIS; HEPATOMEGALY; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; OCCUPATIONAL EXPOSURE; RAT; REVIEW; TOXICOKINETICS;

PRIMATES; RODENTIA;

EID: 0030002143     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408449609048302     Document Type: Review

References (488)

1. Klöpffer, W., Environmental hazard, assessment of chemicals and products. II. Persistence and degradability of organic chemicals, Environ. Sci. Pollut. Res., 1:108-116, 1994.
2. Aso, D., Migita, M., and Tomoda, M., Production of phthalic acid by azotobacter, Proc. 2nd Int. Congr. Soll., 3:40-41, 1932.
3. Schmid, H. and Karrer, P., Über wasserlösliche Inhaltsstoffe von Papaver somniferum, Zürich, Chem. Institut Universität, 722-740, 1945.
4. Mathur, S. P., Phthalate esters in the environment: pollutants or natural products?, J. Environ. Qual., 3:189-196, 1974.
5. Lützel, G., Weichmacher, Kunststoffe, 74:632-635, 1984.
6. Blass, C. R., Jones, C., and Coutney, J. M., Biomaterials for blood tubing: the application of plasticised poly(vinyl chloride), Int. J. Artif. Organs, 15:220-203, 1992.
7. Berndtsson, S., 1984, as cited in Beratergremium für umweltrelevante Altstoffe (BUA) der Gesellschaft Deutscher Chemiker, Di(2-ethylhexyl)phthalat, BUA-Stoffbericht, 4, 1986.
8. Alarie, Y., Iwasaki, M., Sock, M. F., Person, R. C., Shane, B. S., and Lisk, D. J., Effect of inhaled municipal refuse incinerator fly ash in the guinea pig, J. Toxicol. Environ. Health, 28:13-25, 1989.
9. Quackenboss, H. M., Plasticizers in PVC-resins: migration of plasticizers, Ind. Eng. Chem., 46:1335, 1954.
10. Wams, T. J., Diethylhexylphthalate as an environmental contaminant - a review, Sci. Total Environ., 66:1-16, 1987.
11. Giam, C. S., Chan, H. S., Naff, G. S., and Atlas, E. L., Phthalate ester plasticizers: a new class of marine pollutant, Science, 199:419-421, 1978.
12. IPCS/WHO, International Programme on Chemical Safety/World Health Organization, Diethylhexyl phthalate, Environ. Health Criteria, 131:1-141, 1992.
13. Beratergremium für umweltrelevante Altstoffe (BUA) der Gesellschaft Deutscher Chemiker. Di-(2-ethylhexyl)phthalate, BUA-Stoffbericht, 4, 1986.
14. Mayer, F. L., Stalling, D., and Johnson, J. L., Phthalate esters as environmental contaminants, Nature (London), 238:411-413, 1972.
15. Takahashi, M., Ohgane, J., Sato, H., and Sone, M., Esters of phthalic acid in the water of Miyashiro Prefecture (Jpn.), Miyagi-ken Kogai Gijutsu Senta Hokoku, 4:39-41, 1976; (Chem. Abstr., 88:78840k).
16. Takahashi, M., Ohgane, J., Sato, H., and Sone, M., Esters of phthalic acid in the water of Miyashiro Prefecture (Jpn.), Miyagi-ken Kogai Gijutsu Senta Hokoku, 4:39-41, 1976; (Chem. Abstr., 88:78840k).
17. Hrudey, S. E., Sergy, G. A., and Thackeray, T., Toxicity of oil sands plant wastewaters and associated organic contaminants, Water Pollut. Res. Can., 76:34-45, 1976.
18. Mori, S., Identification and determination of phthalate esters in river water by high-performance liquid chromatography, J. Chromatogr., 129:53-60, 1976.
19. Schouten, M. J., Copius Peereboom, J. W., and Brinkman, U. A. T., Liquid chromatographic analysis of phthalate esters in Dutch river water, Int. J. Environ. Anal. Chem., 7:13-23, 1979.
20. IAWR-Rheinbericht, 1981/82, as cited in Beratergremium für umweltrelevante Altstoffe (BUA) der Gesellschaft Deutscher Chemiker. Di-(2-ethylhexyl)phthalat, BUA-Stoffbericht, 4, 1986.
21. Schwartz, H. E., Anzion, C. J. M., Van Vliet, H. P. M., Copius Peereboom, J. W., and Brinkman, U. A. T., Analysis of phthalate esters in sediments from Dutch rivers by means of high performance liquid chromatography, Int. J. Environ. Anal. Chem., 6:133-144, 1979.
22. Malisch, R., Schulte, E., and Acker, L., Chloroorganische Pestizide, polychlorierte Biphenyle und Phthalate in Sedimenten aus Rhein und Neckar, Chem. Zeitung, 105:187-194, 1981.
23. EPA, U.S. Environmental Protection Agency, Paint formulating-point source category: effluent limitations guidelines, pretreatment standards, and new source performance standards. U.S. Code Fed. Regul., Title 40, Part 446, Fed. Regist., 45 (No.2):912-926, 1980.
24. EPA, U.S. Environmental Protection Agency, Ink formulating-point source category: effluent limitations guidelines, pretreatment standards, and new source performance standards. U.S. Code Fed. Regul.; Title 40, Part 447, Fed. Regist., 45 (No. 2):928-939, 1980.
25. Jaeger, R. J. and Rubin, R. J., Contamination of blood stored in plastic packs, Lancet, 2:151, 1970.
26. Jaeger, R. J. and Rubin, R. J., Migration of a phthalate ester plasticizer from polyvinyl chloride blood bags into stored human blood and its localization in human tissues, N. Engl. J. Med., 287:1114-1118, 1972.
27. Piechocki, J. T. and Purdy, W. C., Determination of di-(2-ethylhexyl)-phthalate (DEHP) in human plasma, Clin. Chim. Acta, 48:385-391, 1973.
28. Rock, G., Secours, V. E., Franklin, C. A., Chu, I., and Villeneuve, D. C., The accumulation of mono-2-ethylhexylphthalate (MEHP) during storage of whole blood and plasma, Transfusion, 18:553-558, 1978.
29. Pik, J., Braier, J., Kalman, Z., and Jozef, M., Determination of bis(2-ethylhexyl)phthalate (DEHP) in blood preparations stored in poly(vinyl chloride) bags (Rum.), Probl. Gematol. Per. Krovi., 24:49-51, 1979 (Chem. Abstr., 91:27213n).
30. Pik, J., Braier, J., Kalman, Z., and Jozef, M., Determination of bis(2-ethylhexyl)phthalate (DEHP) in blood preparations stored in poly(vinyl chloride) bags (Rum.), Probl. Gematol. Per. Krovi., 24:49-51, 1979 (Chem. Abstr., 91:27213n).
31. NTP, National Toxicology Program, Carcinogenesis bioassay of di(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 mice (feed study). Tech. Rep. Ser., 217, 1982.
32. Ganning, A. E., Brunk, U., and Dallner, G., Phthalate esters and their effect on the liver, Hepatology, 4:541-547, 1984.
33. Griffiths, W. C., Camara, P. D., Saritelli, A., and Gentile, J., The in vitro serum protein-binding characteristics of bis-(2-ethylhexyl)phthalate and its principal metabolite, mono-(2-ethylhexyl)phthalate, Environ. Health Perspect., 77:151-156, 1988.
34. Plonait, S. L., Nau, H., Maier, R. F., Wittfoht, W., and Obladen, M., Exposure of newborn infants to di(2-ethylhexyl)-phthalate and 2-ethylhexanoic acid following exchange transfusion with Polyvinylchloride catheters, Transfusion, 33:598-605, 1993.
35. Rock, G., Labow, R. S., Franklin, C., Burnett, R., and Tocchi, M., Hypotension and cardiac arrest in rats following infusion of mono(2-ethylhexyl)phthalate (MEHP), a contaminant of stored blood, N. Engl. J. Med., 316:1218-1219, 1987.
36. Labow, R. S., Card, R. T., and Rock, G., The effect of the plasticizer di(2-ethylhexyl) phthalate on red cell deformability, Blood, 70:319-323, 1987.
37. Rubin, R. J. and Schiffer, C. A., Fate in humans of the plasticizer, di-2-ethylhexylphthalate, arising from transfusion of platelets stored in vinyl plastic bags, Transfusion, 16:330-335, 1976.
38. Labow, R. S. and Tocchi, M., Contamination of platelet storage bags by phthalate esters, J. Toxicol. Environ. Health, 19:591-598, 1986.
39. Shimizu, T., Kouketsu, K., Morishima, Y., Goto, S., Hasegawa, I., Kamiya, T., Tamura, Y., and Kora, S., A new Polyvinylchloride blood bag plasticized with less-leachable phthalate ester analogue, din-decyl phthalate, for storage of platelets, Transfusion, 29:292-297, 1989.
40. Vessman, J. and Rietz, G., Determination of di(ethylhexyl)phthalate in human plasma and plasma proteins by electron capture gas chromatography, J. Chromatogr., 100:153-163, 1974.
41. Dine, T., Luyckx, M., Cazin, M., Brunet, C., Cazin, J. C., and Goudaliez, F., Rapid determination by high performance liquid chromatography of di-2-ethylhexyl phthalate in plasma stored in plastic bags, Biomed. Chromatogr., 5:94-97, 1991.
42. Nässberger, L., Arbin, A., and Östelius, J., Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis, Nephron, 45:286-290, 1987.
43. Pearson, S. D. and Trissel, L. A., Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components, Am. J. Hosp. Pharm., 50:1405-1409, 1993.
44. Easterling, R. E., Johnson, E., and Napier, E. A., Plasma extraction of plasticizers from "medical grade" Polyvinylchloride tubing (38389), Proc. Soc. Exp. Biol. Med., 147:572-574, 1974.
45. Lewis, L. M., Flechtner, T. W., Kerkay, J., Pearson, K. H., and Nakamoto, S., Bis(2-ethylhexyl)phthalate concentrations in the serum of hemodialysis patients, Clin. Chem., 24/5:741-746, 1978.
46. Gerstoft, J., Christiansen, E., Nielsen, I. L., and Nielsen, B., The migration of plasticizers from PVC haemodialysis tubes, Proc. Eur. Dial. Transplant. Assoc., 16:739-740, 1980.
47. Bommer, J., Waldherr, R., Gastner, M., Lemmes, R., and Ritz, E., Iatrogenic multiorgan silicone inclusions in dialysis patients, Klin Wochenschr., 59:1149-1157, 1981.
48. Ono, K., Tatsukawa, R., and Wakimoto, T., Migration of plasticizer from hemodialysis blood tubing, J. Am. Med. Assoc., 234:948-949, 1975.
49. Sjöberg, P., Bondesson, U., Sedin, G., and Gustafsson, J., Dispositions of di- and mono-(2-ethylhexyl)phthalate in newborn infants subjected to exchange transfusions, Eur. J. Clin. Invest., 15:430-436, 1985.
50. Shneider, B., Schena, J., Truog, R., Jacobson, M., and Kevy, S., Exposure to di(2-ethylhexyl) phthalate in infants receiving extracorporal membrane oxygenation, N. Engl. J. Med., 320:1563, 1989.
51. Labow, R. S., Tocchi, M., and Rock, G., Effects of leachable materials on morphology and function, Transfusion, 26:351-357, 1986.
52. Martis, L., Freid, E., and Woods, E., Tissue distribution and excretion of tri-(2-ethylhexyl)trimellitate in rats, J. Toxicol. Environ. Health, 20:357-366, 1987.
53. Hoenich, N. A., Thompson, J., Varini, E., McCabe, J., and Appleton, D., Particle spallation and plasticizer (DEHP) release from extracorporeal circuit tubing materials, Int. J. Artif. Organs, 13:55-62, 1990.
54. Rock, G., Labow, R. S., and Tocchi, M., Distribution of di(2-ethylhexyl) phthalate and products in blood and blood components, Environ. Health Perspect., 65:309-316, 1986.
55. Seidl, S., Gosda, W., and Repucci, A. J., The in vitro and in vivo evaluation of whole blood and red cell concentrates drawn on CPDA-1 and stored in a non-DEHP plasticized PVC container, Vox. Sang., 61:8-13, 1991.
56. Gibson, T. P., Briggs, W. A., and Boone, B. J., Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis, J. Lab. Clin. Med., 87:519-524, 1976.
57. CPSC, U.S. Consumer Product Safety Commission, Report to the U.S. Consumer Product Safety Commission by the Chronic Hazard Advisory Panel on Di(2-ethylhexyl)phthalate (DEHP), U.S. Consumer Product Safety Commission, Washington, D.C., 1985.
58. Bommer, J., Ritz, E., and Andrassy, K., Side effects due to materials used in hemodialysis equipment, Adv. Nephrol., 14:409-438, 1985.
59. Pollack, G. M., Buchanan, J. F., Slaughter, R. L., Kohli, R. K., and Shen, D. D., Circulating concentrations of di(2-ethylhexyl)phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis, Toxicol. Appl. Pharmacol., 79:257-267, 1985.
60. Flaminio, L. M., Bergia, R., De Angelis, L., Ferazza, M., Marinovich, M., Galli, G., and Galli, C. L., The fate of leached di-(2-ethylhexyl)-phthalate (DEHP) in patients on chronic haemodialysis, Int. J. Artif. Organs, 11:428-434, 1988.
61. Jacobson, M. S., Kevy, S. V., and Grand, R. J., Effects of plasticizer leached from polyvinyl chloride on the subhuman primate: a consequence of chronic transfusion therapy, J. Lab. Clin. Med., 89:1066-1079, 1977.
62. Sjöberg, P. O., Bondesson, U. G., Sedin, E. G., and Gustafsson, J. P., Exposure of newborn infants to plasticizers. Plasma levels of di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate during exchange transfusion, Transfusion, 25:424-428, 1985.
63. Peck, C. C., Albro, P. W., Haas, J. R., Odom, D. G., Barrett, B. B., and Bailey, F. J., Metabolism and excretion of the plasticizer di-(2-ethylhexyl)-phthalate in man, Clin. Res., 26:101A, 1978.
64. Barry, Y. A., Labow, R. S., Keon, W. J., Tocchi, M., and Rock, G., Perioperative exposure to plasticizers in patients undergoing cardiopulmonary bypass, J. Thorac. Cardiovasc. Surg., 97:900-905, 1989.
65. Roth, B., Herkenrath, P., Lehmann, H.-J., Ohles, H.-D., Hömig, H. J., Benz-Bohm, G., Kreuder, J., and Younossi-Hartenstein, A., Di-(2-ethylhexyl)-phthalate as plasticizer in PVC respiratory tubing system: indications of hazardous effects on pulmonary function in mechanically ventilated, preterm infants, Eur. J. Pediatr., 147:41-46, 1988.
66. Milkow, L. E., Aldyreva, M. V., Popova, T. B., Lopukhova, K. A., Makarenko, Y. L., Malyar, L. M., and Shakova. T. K., Health status of workers exposed to phthalate plasticizers in the manufacture of artificial leather and films based on PVC resins, Environ. Health Perspect., 3:175-178, 1973.
67. Gilioli, R., Bulgheroni, C., Terrana, T., Filippini, G., Massetto, N., and Boeri, R., Studio neurologico transversale e longitudinale di una popolazione operaia addetta alla produzione di ftalati, Med. Lav., 69:620-631, 1978.
68. Thiess, A. M. and Fleig, I., Chromosomenuntersuchungen bei Mitarbeitern mit Exposition gegenüber Di-(2-ethylhexyl)phthalat (DOP), Zentralbl. Arbeitsmed. Arbeitsschutz, 28:351-356, 1978.
69. Thiess, A. M., 1978, as cited in Beratergremium für umweltrelevante Altstoffe (BUA) der Gesellschaft Deutscher Chemiker. Di-(2-ethylhexyl)phthalat, BUA-Stoffbericht, 4, 1986.
70. Ruhe, R. L. and Donohue, M., Health Hazard Evaluation Determination Report HE 78-91-621, Dresser Industries, Inc., Bradford, PA, U.S. Department of Health, Education, and Welfare, National Institute for Occupational Safety and Health, Cincinnati, OH, 1979.
71. Nielsen, J., Akesson, B., and Skerfving, S., Phthalate ester exposure - air levels and health of workers processing Polyvinylchloride, Am. Ind. Hyg. Assoc. J., 46:643-647, 1985.
72. Liss, G. M., Albro, P. W., Hartle, R. W., and Stringer, W. T., Urine phthalate determinations as an index of occupational exposure to phthalic anhydride and di(2-ethylhexyl) phthalate, Scand. J. Work Environ. Health, 11:381-387, 1985.
73. Vainiotalo, S. and Pfäffli, P., Air impurities in the PVC-plastics processing industry, Ann. Occup. Hyg., 34:585-590, 1990.
74. Dirven, H. A. A. M., van den Broek, P. H. H., and Jongeneelen, F. J., Determination of four metabolites of the plasticizer di(2-ethylhexyl)phthalate in human urine samples, Int. Arch. Occup. Environ. Health, 64:549-554, 1993.
75. Natow, M., Über das Auswandern von Weichmachern aus Polyvinylchloriderzeugnissen, Plaste Kautschuk, 28:459-460, 1981.
76. Mieure, J. P. and Dietrich, M. W., Determination of trace organics in air and water, J. Chromatogr. Sci., 11:559-570, 1973.
77. NRC, National Research Council, Drinking Water and Health, National Academy of Sciences, Washington, D.C., 1977, 727.
78. Sheldon, L. S. and Hites, R. A., Sources and movement of organic chemicals in the Delaware River, Environ. Sci. Technol., 13:574-579, 1979.
79. NIH/EPA Chemical Information System, Data Bases, Distribution Register of Organic Pollutants in Water (WDROP), Washington, D.C., CIS Project, Information Sciences Corporation, 1981.
80. Fishbein, L., Exposure from occupational versus other sources, Scand. J. Work Environ. Health, 18(Suppl. 1):5-16, 1992.
81. Thuren, A. and Larsson, P., Phthalate esters in the Swedish atmosphere (abstract), Environ. Sci. Technol., 24:554, 1990.
82. Antonyuk, O. K., Toxicology of complex ethers of phthalic acid (a review of literature), Hyg. Labour Occup. Dis., 1:32-35, 1975.
83. Cohen, H., Charrier, C., and Sarfaty, J., Extraction and identification of a plasticizer, di-(2-ethylhexyl)phthalate, from a plastic bag containing contaminated corn, Arch. Environ. Contam. Toxicol., 20:437-440, 1991.
84. Hartung, R., Toxicological and environmental issues associated with phthalic acid esters - an update since 1974, Washington, D.C., Manufacturing Chemists Association, 1976, 4.
85. Musial, C. J. and Uthe, J. F., Studies on phthalate esters in western atlantic finfish. Report to the Intern. Council of the Expl. of the Sea. ICES, D.M., 1980/E, 11.
86. EPA, U.S. Environmental Protection Agency, Ambient Water Quality Criteria for Phthalate Esters (NTIS Publication No. PB81-117780), Washington, D.C., 1980, C-4-C-5.
87. USATSDR, Toxicological profile for di(2-ethylhexyl) phthalate, Atlanta, Georgia, Agency for Toxic Substances and Disease Registry, U.S. Public Health Service (Draft for public comment), 1988.
88. Castle, L., Mayo, A., and Gilbert, J., Migration of plasticizers from printing inks into foods, Food Addit. Contam., 6:437-443, 1989.
89. EC-Commission, Directorate General for Industrial Affairs and International Market, Consolidated report of the scientific committee for food on certain additives used in the manufacture of plastic materials intended to come into contact with foodstuffs; CS/PM/1023, 1991.
90. Nakamura, Y., Yagi, Y., Tomita, I., and Tsuchikawa, K., Teratogenicity of di-(2-ethylhexyl)phthalate in mice, Toxicol. Lett., 4:113-117, 1979.
91. Shiota, K., Chou, M. J., and Nishimura, H., Embryotoxic effects of di-2-ethylhexyl phthalate (DEHP) and di-n-butyl phthalate (DBP) in mice, Environ. Res., 22:245-253, 1980.
92. MAFF, Survey of plasticiser level in food contact materials and in foods, London, Ministry of Agriculture, Fisheries and Food (Food Surveillance Paper No. 21), 1987.
93. ECETOC: Tech. Rep. No. 18, Assessment of non-occupational exposure to chemicals, 1994.
94. Scott, R. C., Dugard, P. H., Ramsey, J. D., and Rhodes, C., In vitro absorption of some o-phthalate diesters through human and rat skin, Environ. Health Perspect., 74:223-227, 1987.
95. Little, A. D., Phthalates in consumer products. Contr. CPSC-C-80-1001. Consumer Product Safety Commission, 1982.
96. Rodricks, J. and Turnbull, D., Assessment of possible carcinogenic risk resulting from exposure to di-(2-ethylhexyl)phthalate (DEHP) in children's products. Prepared for Chemical Manufacturers Association, Washington, D.C., 1984.
97. U.S. Department of Health and Human Services, 1983, quoted in: Bronsch, C. J. T., Untersuchungen zur Exposition und zurn renalen Ausscheidungsverhalten des Kunsstoffweichmachers Di(2-Ethylhexyl)Phthalat (DEHP) beim Menschen, Ph.D. thesis no. 8459, ETH Zürich, Switzerland, 1987.
98. Turnbull, D. and Rodricks, J. V., Assessment of possible carcinogenic risk to humans resulting from exposure to di(2-ethylhexyl)phthalate (DEHP), J. Am. College Toxicol., 4:111-145, 1985.
99. Bronsch, C. J. T., Untersuchungen zur Exposition und zum renalen Ausscheidungsverhalten des Kunsstoffweichmachers Di(2-Ethylhexyl)Phthalat (DEHP) beirn Menschen, Ph.D. thesis, no. 8459, ETH Zürich, Switzerland, 1987.
100. Labow, R. S., Meek, E., Adams, G. A., and Rock, G., Inhibition of human platelet phospholipidase A2 by mono(2-ethylhexyl)phthalate, Environ. Health Perspect., 78:179-183, 1988.
101. Reddy, J. K. and Lalwani, N. D., Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans, Crit. Rev. Toxicol., 12:1-58, 1983.
102. Albro, P. W., Absorption, metabolism, and excretion of di(2-ethylhexyl) phthalate by rats and mice, Environ. Health Perspect., 65:293-298, 1986.
103. Albro, P. W., Corbett, J. T., Schroeder, J. L., Jordon, S., and Matthews, H. B., Pharmacokinetics, interactions with macromolecules, and species differences in metabolism of DEHP, Environ. Health. Perspect., 45:19-25, 1982.
104. Chu, I., Villeneuve, D. C., Secours, V., Franklin, C., Rock, G., and Viau, A., Metabolism and tissue distribution of mono-2-ethylhexyl phthalate in the rat, Drug Metab. Dispos., 6:146-149, 1978.
105. Albro, P. W., Thomas, R., and Fishbein, L., Metabolism of di-ethylhexylphthalate by rats. Isolation and characterization of the urinary metabolites, J. Chromatogr., 76:321-330, 1973.
106. Astill, B. D., Metabolism of DEHP: effects of prefeeding and dose variation, and comparative studies in rodents and the cynomolgus monkey (CMA studies), Drug Metab. Rev., 21:35-53, 1989.
107. Albro, P. W., Metabolism of di(2-ethylhexyl)phthalate, Drug Metab. Rev., 21:13-34, 1989.
108. Lake, B. G., Gray, T. J. B., Foster, J. R., Stubberfield, C. R., and Gangolli, S. D., Comparative studies on di(2-ethylhexyl)phthalate-induced hepatic peroxisome proliferation in the rat and hamster, Toxicol. Appl. Pharmacol., 72:46-60, 1984.
109. Rhodes, C., Orton, T. C., Pratt, I. S., Batten, P. L., Bratt, H., Jackson, S. J., and Elcombe, C. R., Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl)phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man, Environ. Health Perspect., 65:299-307, 1986.
110. Schmid, P. and Schlatter, C., Excretion and metabolism of di-(2-ethylhexyl)phthalate in man, Xenobiotica, 15:251-256, 1985.
111. Dirven, H. A. A. M., van den Broek, P. H. H., and Jongeneelen, F. J., Determination of four metabolites of the plasticizer di(2-ethylhexyl)phthalate in human urine samples, Int. Arch. Occup. Environ. Health, 64:555-560, 1993.
112. Short, R. D., Robinson, E. C., Lington, A. W., and Chin, A. E., Metabolic and peroxisome proliferation studies with di(2-ethylhexyl)phthalate in rats and monkeys, Toxicol. Ind. Health, 3:185-195, 1987.
113. Peck, C. C., Odorn, D. G., Friedman, H. T., Albro, P. W., Hass, J. R., Brady, J. T., and Tess, D., Di-(2-ethylhexyl)phthalate (DEHP) and mono-(2-ethylhexyl)phthalate (MEHP) accumulation in whole blood and red cell concentrates, Transfusion, 19:137-146, 1979.
114. Albro, P. W., Hass, J. R., Peck, C. C., Odam, D. G., Corbett, J. T., Bailey, F. J., Blatt, H. E., and Barrett, B. B., Identification of the metabolites of di(2-ethylhexyl)phthalate in urine from the African Green monkey, Drug Metab. Dispos., 9:223-225, 1979.
115. Teirlynck, O. A. and Belpaire, F., Disposition of orally administered di(2-ethylhexyl)phthalate and mono-(2-ethylhexyl)phthalate in the rat, Arch. Toxicol., 57:226-230, 1985.
116. Pollack, G. M., Li, R. C. K., Ermer, J. C., and Shen, D. D., Effects of route of administration and repetitive dosing on the disposition kinetics of di(2-ethylhexyl)phthalate and its mono-de-esterified metabolite in rats, Toxicol. Appl. Pharmacol., 79:246-256, 1985.
117. Elsisi, A. E., Carter, D. E., and Sipes, I. G., Dermal absorption of phthalate diesters in rats, Fundam. Appl. Toxicol., 12:70-77, 1989.
118. Barber, E. D., Teetsel, N., Kolberg, K. F., and Guest, D., A comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skin, Fundam. Appl. Toxicol., 19:493-497, 1992.
119. Tanaka, A., Adachi, T., Takahashi, T., and Yamaha, T., Biochemical studies on phthalic esters. I. Elimination, distribution and metabolism of di-(2-ethylhexyl)phthalate in rats, Toxicology, 4:253-264, 1975.
120. Daniel, J. W. and Bratt, H., The absorption, metabolism and tissue distribution of di(2-ethylhexyl)phthalate in rats, Toxicology, 2:51-65, 1974.
121. Oishi, S. and Hiraga, K., Distribution and elimination of di-2-ethylhexyl phthalate (DEHP) and mono-2-ethylhexyl phthalate (MEHP) after a single oral administration of DEHP in rats, Arch. Toxicol., 51:149-155, 1982.
122. Oishi, S., Effects of phthalic acid esters on testicular mitochondrial functions in the rat, Arch. Toxicol., 64:143-147, 1990.
123. Sjöberg, P., Bodesson, U., Gray, T. J. B., and Plöen, L., Effects of di-(2-ethylhexyl) phthalate and five of its metabolites on rat testis in vivo and in vitro, Acta Pharmacol. Toxicol., 58:225-233, 1986.
124. Oishi, S., Effects of co-administration of di(2-ethylhexyl)phthalate and testosterone on several parameters in the testis and pharmacokinetics of its monode-esterified metabolite, Arch. Toxicol., 63:289-295, 1989.
125. Sjöberg, P., Bodesson, U., Kjellen, L., Lindquist, N.-G., Montin, G., and Plöen, L., Kinetics of di-(2-ethylhexyl) in immature and mature rats and effect on testis, Acta Pharmacol. Toxicol., 56:30-37, 1986.
126. Sjöberg, P., Bodesson, U., and Hammarlund, M., Non-linearities in the pharmakokinetics of di-(2-ethylhexyl) phthalate in metabolites in male rats, Arch. Toxicol., 58:72-77, 1985.
127. Dostal, L. A., Weaver, R. P., and Schwetz, B. A., Transfer of di(2-ethylhexyl)phthalate through rat milk and effects on milk composition and the mammary gland, Toxicol. Appl. Pharmacol., 91:315-325, 1987.
128. Chen, W. S., Kerkay, J., Pearson, K. H., Paganini, E. P., and Nakamoto, S., Tissue bis(2-ethylhexyl)phthalate levels in uremic subjects, Anal. Lett., 12:1517-1535, 1979.
129. Christensson, A., Ljunggren, L., Nilsson-Thorell, C., Arge, B., Diehl, U., Hagstam, K. E., and Lundberg, M., In vivo comparative evaluation of hemodialysis tubing plasticized with DEHP and TETHM, Int. J. Artif. Organs, 14:407-410, 1991.
130. Shneider, B., Cronin, J., Van Marter, L., Maller, E., Truog, R., Jacobson, M., and Kevy, S., A prospective analysis of cholestasis in infant supported with extracorporeal membrane oxygenation, J. Pediatr. Gastroenterol. Nutr., 13:285-289, 1991.
131. Mes, J., Coffin, D. E., and Campbell, D. S., Di-n-butyl and di-2-ethylhexyl phthalate in human adipose tissue, Bull. Environ. Contam. Toxicol., 12:721-725, 1974.
132. Stott, W. T., Chemically induced proliferation of peroxisomes, Regul. Toxicol. Pharmacol., 8:125-159, 1988.
133. ECETOC: Monograph No. 17, Hepatic peroxisome proliferation, 1992.
134. Lock, E. A., Mitchell, A. M., and Elcombe, C. R., Biochemical mechanisms of induction of hepatic peroxisome proliferation, Annu. Rev. Pharmacol. Toxicol., 29:145-163, 1989.
135. Reubsaet, F. A. G., Veerkamp, J. H., Bukkens, S. G. F., Trijbels, J. M. F., and Monnens, L. A. H., Acyl-CoA oxidase activity and peroxisomal fatty acid oxidation in rat tissues, Biochim. Biophys. Acta, 958:434-442, 1988.
136. Ganning, A. E., Olsson, M. J., Brunk, C., and Dallner, G., Effects of prolonged treatment with phthalate ester on rat liver, Pharmacol. Toxicol., 68:392-401, 1991.
137. Mitchell, F. E., Price, S. C., Hinton, R. H., Grasso, P., and Bridges, J. W., Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl)phthalate. Toxicol. Appl. Pharmacol., 81:371-392, 1985.
138. Reddy, J. K., Reddy, M. K., Usman, M. I., Lalwani, N. D., and Rao, M. S., Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate, with a hypolipidemic drug, Environ. Health Perspect., 65:317-327, 1986.
139. Osumi, T. and Hashimoto, T., Enhancement of fatty acyl-CoA oxidizing activity in rat liver peroxisomes by di(2-ethylhexyl)phthalate, J. Biochem. (Tokyo), 83:1361-1365, 1978.
140. Khaliq, M. A. and Srivastava, S. P., Induction of hepatic polyamines by di(2-ethylhexyl)phthalate in rats, Toxicol. Lett., 66:317-321, 1993.
141. Dirven, H. A. A. M., van den Broek, P. H. H., and Jongeneelen, F. J., Effect of di(2-ethylhexyl)phthalate on enzyme activity levels in liver and serum of rats, Toxicology, 65:199-207, 1990.
142. Tomaszewski, K. E., Derks, M. C., and Melnick, R. L., Acyl CoA oxidase is the most suitable marker for hepatic peroxisomal changes caused by treatment of F344 rats with di(2-ethylhexyl)phthalate, Toxicol. Lett., 37:203-212, 1987.
143. Dostal, L. A., Jenkins, W. L., and Schwetz, B. A., Hepatic peroxisome proliferation and hypolipidemic effects of di(2-ethylhexyl)phthalate in neonatal and adult rats, Toxicol. Appl. Pharmacol., 87:81-90, 1987.
144. Sharma, R., Lake, B. G., and Gibson, G. G., Coinduction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate, Biochem. Pharmacol., 37:1203-1206, 1988.
145. Dirven, H. A. A. M., van den Broek, P. H. H., Peters, J. G. P., Noordhoek, J., and Jongeneelen, F. J., Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P-450 inducers and peroxisome proliferating compounds, Biochem. Pharmacol., 43:2621-2629, 1992.
146. Dirven, H. A. A. M., de Bruijn, A. A. G. M., Sessink, P. J. M., and Jongeneelen, F. J., Determination of the cytochrome P-450 IV marker, omega-hydroxylauric acid, by high-performance liquid chromatography and fluorimetric detection, J. Chromatogr., 564:266-271, 1991.
147. Cattley, R. C., Conway, J. G., and Popp, J. A., Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for two years, Cancer Lett., 38:15-22, 1987.
148. Barber, E. D., Astill, B. D., Moran, E. J., Schneider, B. F., Gray, T. J. B., Lake, B. G., and Evans, J. G., Peroxisome induction studies on seven phthalate esters, Toxicol. Ind. Health, 3:7-24, 1987.
149. Ochs, J. B., L. A., B., Leonard, D. A., and Calabrese, E. J., Effects of joint exposures to selected peroxisome proliferators on hepatic acyl-CoA oxidase activity in male B6C3F1 mice, Hum. Exp. Toxicol., 11:83-88, 1992.
150. Tomaszewski, K. E., Montgomery, C. A., and Melnick, R. L., Modulation of 2,3,7,8-tetrachloridibenzo-p-dioxin toxicity in F344 rats by di(2-ethylhexyl)phthalate, Chem. Biol. Interact., 65:205-222, 1988.
151. Melnick, R. L., Morrissey, R. E., and Tomaszewski, K. E., Studies by the national toxicology program on di(2-ethylhexyl)phthalate, Toxicol. Ind. Health, 3:99-118, 1987.
152. Tamura, H., Iida, T., Watanabe, T., and Suga, T., Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats, Carcinogenesis, 11:445-450, 1990.
153. Hinton, R. H., Mitchell, F. E., Mann, A., Chescoe, D., Price, S. C., Nunn, A., Grasso, P., and Bridges, J. W., Effects of phthalic acid esters on the liver and thyroid, Environ. Health Perspect., 70:195-210, 1986.
154. Ganning, A. E. and Dallner, G., Induction of peroxisomes and mitochondria by di(2-ethylhexyl)phthalate, FEBS Lett., 130:77-79, 1981.
155. Marsman, D. S., Cattley, R. C., Conway, J. G., and Popp, J. A., Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and (4-chloro-6-(2,3-xylidino) -2-pyrimidinylthio)acetic acid (Wy-14,643) in rats, Cancer Res., 48:6739-6744, 1988.
156. Cattley, R. C., Smith-Oliver, T., Butterworth, B. E., and Popp, J. A., Failure of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment, Carcinogenesis, 9:1179-1183, 1988.
157. Ward, J. M., Hagiwara, A., Anderson, L. M., Lindsey, K., and Diwan, B. A., The chronic hepatic or renal toxicity of di(2-ethylhexyl)phthalate, acetaminophen, sodium barbital, and phenobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical, and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion, Toxicol. Appl. Pharmacol., 96:494-506, 1988.
158. Nixon, J. and Jackson, S. J., Bis(2-ethylhexyl)-phthalate: a comparative subacute toxicity study in the rat and marmoset. Tech. Rep. No. CTL/P/690. Prepared for CEFIC (European Council of the Federation of the Chemical Industry), 1982.
159. Elliott, B. M. and Elcombe, C. R., Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisome proliferators, Carcinogenesis, 8:1213-1287, 1987.
160. Tomaszewski, K. E., Agarwal, D. K., and Melnick, R. L., In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators, Carcinogenesis, 7:1871-1876, 1986.
161. Elliott, B. M., Dodd, N. J. F., and Elcombe, C. R., Increased hydroxyl radical production in peroxisomal fractions from rats treated with peroxisome proliferators, Carcinogenesis, 7:795-799, 1986.
162. Badr, M. Z., Induction of peroxisomal enzyme activities bi di-(2-ethylhexyl)phthalate in thyroidectomized rats with parathyroid replants, J. Pharmacol. Exp. Ther., 263:1105-1110, 1992.
163. Sharma, R., Lake, B. G., Foster, J., and G. G., G., Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidemic agents in rat liver. A mechanistic inter-relationship, Biochem. Pharmacol., 37:1193-1201, 1988.
164. Okita, R. T. and Rice Okita, J., Characterization of a cytochrome P450 from di(2-ethylhexyl) phthalate-treated rats which hydroxylates fatty acids, Arch. Biochem. Biophys., 294:475-481, 1992.
165. Nair, N. and Kurup, R., A comparative study of the effects of administration of diethylhexyl phthalate on hepatic mitochondria of the rat and the mouse, Indian J. Biochem. Biophys., 23:270-273, 1986.
166. Nair, N. and Kurup, R., Are the hypocholesterolaemic action and metabolic effects of diethylhexyl phthalate mediated by thyroxine?, Indian J. Biochem. Biophys., 23:76-79, 1986.
167. Yanagita, T., Satoh, M., Nomura, H., Enomoto, N., and Sugano, M., Alteration of hepatic phospholipids in rats and mice by feeding di-(2-ethylhexyl)adipate and di-(2-ethylhexyl)phthalate, Lipids, 22:572-577, 1987.
168. Lake, B. G., Gray, T. J. B., and Gangolli, S. D., Hepatic effects of phthalate esters and related compounds - in vivo and in vitro correlations, Environ. Health Perspect., 67:283-290, 1986.
169. Reubsaet, F. A. G., Veerkamp, J. H., Dirven, H. A. A. M., Brückwilder, M. L. P., Hashimoto, T., Trijbels, J. M. F., and Monnens, L. A. H., The effect of di(ethylhexyl) phthalate on fatty acid oxidation and carnitine palmitoyltransferase in various rat tissues, Biochim. Biophys. Acta, 1047:264-270, 1990.
170. Reubsaet, F. A. G., Veerkamp, J. H., Dirven, H. A. A. M., Brückwilder, M. L. P., Trijbels, J. M. F., and Monnens, L. A. H., Peroxisomal oxidases and catalase in liver and kidney homogenates of normal and di(ethylhexyl)phthalate-fed rats, Int. J. Biochem., 23:961-967, 1991.
171. Ghesquier, D., Cook, L., Nagi, M. N., MacAlister, T. J., and Cinti, D. L., Source of the hepatic microsomal trans-2-enoyl CoA hydratase bifunctional protein: endoplasmic reticulum or peroxisomes, Arch. Biochem. Biophys., 252:369-381, 1987.
172. Kawashima, Y., Nakagawa, S., Tachibana, Y., and Kozuka, H., Effects of peroxisome proliferators on fatty acid-binding protein in rat liver, Biochim. Biophys. Acta, 754:21-27, 1983.
173. Kawashima, Y., Matsunaga, T., Hirose, A., Ogata, T., and Kozuka, H., Induction of microsomal 1-acylglycerophosphocholine acyltransferase by peroxisome proliferators in rat kidney; co-induction with peroxisomal β-oxidation, Biochim. Biophys. Acta, 1006:214-218, 1989.
174. Hodgson, J. R., Results of peroxisome induction studies on tri(2-ethylhexyl)-trimellitate and 2-ethylhexanol, Toxicol. Ind. Health, 3:49-61, 1987.
175. Topping, D. C., Ford, G. P., Evans, J. G., Lake, B. G., O'Donoghue, J. L., and Lockhart, H. B. J., Peroxisome induction studies on
176. Takagi, A., Sai, K., Umemura, T., Hasegawa, R., and Kurokawa, Y., Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators, J. Environ. Pathol. Toxicol. Oncol., 11:145-149, 1992.
177. Butterworth, B. E., Bermudez, E., Smith-Oliver, T., Earle, L., Cattley, R., Martin, J., Popp, J. A., Strom, S., Jirtle, R., and Michalopoulos, G., Lack of genotoxic activity of di(2-ethylhexyl)phthalate (DEHP) in rat and human hepatocytes, Carcinogenesis, 5:1329-1335, 1984.
178. Rao, M. S., Yeldandi, A. V., and Subbarao, V., Quantitative analysis of hepatocellular lesions induced by di(2-ethylhexyl)phthalate in F-344 rats, J. Toxicol. Environ. Health, 30:85-89, 1990.
179. Osumi, T. and Hashimoto, T., Subcellular distribution of the enzymes of the fatty acyl-CoA β-oxidation system and their induction by di(2-ethylhexyl) phthalate in rat liver, J. Biochem. (Tokyo), 85:131-139, 1979.
180. Lake, B. G., L., K. S., Evans, J. G., Gray, T. J. B., Young, P. J., and Gangolli, S. D., Effect of prolonged administration of clofibric acid and di(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat, Toxicology, 44:213-228, 1987.
181. Jayaraman, S., Anila Kumar, K. R., and Rama Rao, M. V., Di-2-ethylhexylphthalate induced peroxidative stress in rat liver, Bull. Environ. Contam. Toxicol., 41:360-364, 1988.
182. Reddy, J. K., Moody, D. E., Azarnoff, D. L., and Rao, M. S., Di(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rats and mice, Life Sci., 18:941-946, 1976.
183. Hashimoto, T., Individual peroxisomal β-oxidation enzymes, Ann. N. Y. Acad. Sci., 386:5-12, 1982.
184. Gibson, G. G., Orton, T. C., and Tamburini, P. P., Cytochrome P-450 induction by clofibrate. Purification of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid), Biochem. J., 203:161-168, 1982.
185. Tamburini, P. P., Masson, H. A., Bains, S. K., Makowski, R. J., Morris, B., and Gibson, G. G., Multiple forms of hepatic cytochrome P-450. Purification, characterisation and comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome P-450, Eur. J. Biochem., 139:235-246, 1984.
186. Sundseth, S. S. and Waxman, D. J., Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone, J. Biol. Chem., 267:3915-3921, 1992.
187. Okita, J. R., Castle, P. J., and Okita, R. T., Characterization of cytochromes P450 in liver and kidney of rats treated with di(2-ethylhexyl)phthalate, J. Biochem. Toxicol., 8:135-144, 1993.
188. Levine, W. G., Ord, M. G., and Stocken, L. A., Some biochemical changes associated with nafenopin-induced liver growth in the rat, Biochem. Pharmacol., 26:939-942, 1977.
189. Moody, D. E., Rao, M. S., and Reddy, J. K., Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin, Virchows Arch. [B], 23:291-296, 1977.
190. Smith-Oliver, T. and Butterworth, B. E., Correlation of the carcinogenic potential of di(2-ethylhexyl)-phthalate (DEHP) with induced hyperplasia rather than with genotoxic activity, Mutat. Res., 188:21-28, 1987.
191. Butterworth, B. E., Loury, D. J., Smith-Oliver, T., and Cattley, R. C., The potential role of chemically-induced hyperplasia in the carcinogenic activity of the hypolipidemic carcinogens, Toxicol. Ind. Health, 3:129-149, 1987.
192. I-Kuei Lin, L., The use of multivariate analysis to compare peroxisome induction data on phthalate esters in rats, Toxicol. Ind. Health, 3:25-47, 1987.
193. Wada, N., Marsman, D. S., and Popp, J. A., Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication, Fundam. Appl. Toxicol., 18:149-154, 1992.
194. Bieri, F., Staeubli, W., Waechter, F., Muakkassah-Kelly, S., and Bentley, P., Stimulation of DNA synthesis but not of peroxisomal β-oxidation by nafenopin in primary cultures of marmoset hepatocytes, Cell Biol. Int. Rep., 12:1077-1087, 1988.
195. Dwivedi, R. S., Alvares, K., Nemali, M. R., Subbarao, V., Reddy, M. K., Usman, M. I., Rademaker, A. W., Reddy, J. K., and Rao, M. S., Comparison of the peroxisome proliferator-induced pleiotropic response in the liver of nine strains of mice, Toxicol. Pathol., 17:16-26, 1989.
196. Budroe, J. D., Umemura, T., Angeloff, K., and Williams, G. M., Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL/6N and BALB/c mice, Toxicol. Appl. Pharmacol., 113:192-198, 1992.
197. Kraupp-Grasl, B., Huber, W., Just, W., Gibson, G., and Schulte-Hermann, R., Enhancement of peroxisomal enzymes, cytochrome P-452, and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin, Carcinogenesis, 14:1007-1012, 1993.
198. Grasl-Kraupp, B., Huber, W., Timmermann-Trosiener, I., and Schulte-Hermann, R., Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin, Carcinogenesis, 14:2435-2437, 1993.
199. Lake, B., Evans, J. G., Gray, T. J. B., Körösi, S. A., and North, C. J., Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset, Toxicol. Appl. Pharmacol., 99:148-160, 1989.
200. Gibson, G. G. and Lake, B. G., Induction protocols for the cytochrome P450IVA subfamily in animals and primary hepatocyte cultures, Methods Enzymol., 206:353-364, 1991.
201. Huber, W., Kraupp-Grasl, B., Esterbauer, H., and Schulte-Hermann, R., Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat, Cancer Res., 51:1789-1792, 1991.
202. Huber, W. W., Kraupp-Grasl, B., and Gschwentner, C., Influence of circadian rhythm, feeding rhythm and fat charge on lipid peroxidation under peroxisome proliferation by nafenopin (abstract), Naunyn-Schmiedebergs Arch. Pharmacol., 345(Suppl. 153), 1992.
203. Eacho, P. I., Lanier, T. L., and Brodhecker, C. A., Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883, Carcinogenesis, 12:1557-1561, 1991.
204. Makowska, J. M., C., A., Goldfarb, P. S., Bonner, F., and G. G., G., Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strains, Biochem. Pharmacol., 40:1083-1093, 1990.
205. Lake, B. G., Gray, T. J. B., Lewis, D. F. V., Beamand, J. A., Hodder, K. D., Purchase, R., and Gangolli, S. D., Structure-activity relationships for induction of peroxisomal enzyme activities by phthalate monoesters in primary rat hepatocyte cultures, Toxicol. Ind. Health, 3:165-183, 1987.
206. Mitchell, F. E., Bridges, J. W., and Hinton, R. H., Effects of mono (2-ethylhexyl) phthalate and its straight chain analogues mono-n-hexylphthalate and mono-n-octylphthalate on lipid metabolism in isolated hepatocytes, Biochem. Pharmacol., 35:2941-2947, 1986.
207. Mann, A. H., Price, S. C., Mitchell, F. E., Grasso, P., Hinton, R. H., and Bridges, J. W., Comparison of the short-term effects of di(2-ethylhexyl) phthalate, di(n-hexyl) phthalate, and di(n-octyl) phthalate in rats, Toxicol. Appl. Pharmacol., 77:116-132, 1985.
208. Gray, T. J. B., Lake, B. G., Beamand, J. A., Foster, J. R., and Gangolli, S. D., Peroxisomal effects of phthalate esters in primary cultures of rat hepatocytes, Toxicology, 28:167-179, 1983.
209. Marsman, D. S., Goldsworthy, T. L., and Popp, J. A., Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid, Carcinogenesis, 13:1011-1017, 1992.
210. Yeldandi, A. V., Milano, M., Subbarao, V., Reddy, J. K., and Rao, M. S., Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis, Cancer Lett., 47:21-27, 1988.
211. Barrass, N. C., Price, R. J., Lake, B. G., and Orton, T. C., Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver, Carcinogenesis, 14:1451-1456, 1993.
212. Pill, J., Völkl, A., Hartig, F., and Fahimi, H. D., Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes, Arch. Toxicol., 66:327-333, 1992.
213. Pacot, C., Petit, M., Caira, F., Rollin, M., Behechti, N., Gregoire, S., Malki, M. C., Cavatz, C., Moisant, M., Moreau, C., Thomas, C., Descotes, G., Gallas, J.-F., Deslex, P., Althoff, J., Zahnd, J.-P., Lhuguenot, J.-C., and Latruffe, N., Response of genetically obese Zucker rats to ciprofibrate, a hypolipidemic agent, with peroxisome proliferation activity as compared to Zucker lean and Sprague-Dawley rats, Biol. Cell, 77:27-35, 1993.
214. Lundgren, B. and DePierre, J. W., Proliferation of peroxisomes and induction of cytosolic and microsomal epoxide hydrolase in different strains of mice and rats after dietary treatment with clofibrate, Xenobiotica, 19:867-881, 1989.
215. DeAngelo, A. B., Daniel, F. B., McMillan, L., Wemsing, P., and Savage, Jr., R. E., Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids, Toxicol. Appl. Pharmacol., 101:285-298, 1989.
216. Biegel, L. B., Hurtt, M. E., Frame, S. R., Applegate, M., O'Connor, J. C., and Cook, J. C., Comparison of the effects of Wyeth-14,643 in Crl:CD BR and Fisher-344 rats, Fundam. Appl. Toxicol., 19:590-597, 1992.
217. Nourooz-Zadeh, J., Winder, B. S., Dietze, E. C., Giometti, C. S., Tollaksen, S. L., and Hammock, B. D., Biochemical characterization of a variant form of cytosolic epoxide hydrolase induced by parental exposure to N-ethyl-n-nitrosurea, Comp. Biochem. Physiol. [C], 103:207-214, 1992.
218. Butler, E. G., England, P. J., and Williams, G. M., Genetic differences in enzymes associated with peroxisome proliferation and hydrogen peroxide metabolism in inbred mouse strains, Carcinogenesis, 9:1459-1463, 1988.
219. Small, G. M., Burdett, K., and Connock, N. V., Clofibrate-induced changes in enzyme activities in liver, kidneys, and small intestine of male mice, Ann. N.Y. Acad. Sci., 386:460-463, 1982.
220. Issemann, I. and S., G., Activation of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347:645-650, 1990.
221. Reddy, J. K., Azarnoff, D. K., and Hignite, C. E., Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens, Nature, 283:397-398, 1980.
222. Jäckh, R., Rhodes, C., Grasso, P., and Carter, J. T., Genotoxicity studies on di-(2-ethylhexyl) phthalate and toxicity studies on di-(2-ethylhexyl)phthalate in the rat and marmoset, Food. Chem. Toxicol., 22:151-155, 1984.
223. Cerutti, P. A., Prooxidant states and tumor promotion, Science, 227:375-381, 1985.
224. Schulte-Hermann, R., A review: tumor promotion in the liver, Arch. Toxicol., 57:147-158, 1985.
225. Schulte-Hermann, R., Timmermann Trosiener, I., Barthel, G., and Bursch, W., DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion, Cancer Res., 50:5127-5135, 1990.
226. Marsman, D. S. and Barrett, J. C., Apoptosis and chemical carcinogenesis, Risk. Anal., 14:321-326, 1994.
227. Kikuta, Y., Kusunose, E., Okumoto, T., Kubota, I., and Kusunose, M., Purification and characterization of two forms of cytochrome P-450 with omega-hydroxylase activities toward prostaglandin A and fatty acids from rabbit liver microsomes, J. Biochem. (Tokyo), 107:280-286, 1990.
228. Makowska, J. M., Bonner, F. W., and Gibson, G. G., Comparative action of cytochrome P450IVAI and peroxisome proliferation by ciprofibrate in the rat and marmoset, Arch. Toxicol., 65:106-113, 1991.
229. Reddy, J. K., Lalwani, N. D., Qureshi, S. A., Reddy, M. K., and Moehle, C. M., Induction of hepatic peroxisome proliferation in nonrodent species, including primates, Am. J. Pathol., 114:171-183, 1984.
230. Makowska, J. M., Gibson, G. G., and Bonner, F. W., Species differences in ciprofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation, J. Biochem. Toxicol., 7:183-191, 1992.
231. Orton, T. C., Adam, H. K., Bentley, M., Holloway, B., and Tucker, M. J., Clobuzarit: species differences in the morphological and biochemical response of the liver following chronic administration, Toxicol. Appl. Pharmacol., 73:138-151, 1984.
232. Blane, G. F. and Pinaroli, F., Fenofibrate: etudes de toxicologie animal en rapport avec les effets secondaires chez les malades, Presse Med., 9:3737-3746, 1980.
233. Orton, T. C. and Parker, G. L., The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid, Drug Metab. Dispos., 10:110-115, 1982.
234. Holloway, B. R. and Thorp, J. M., Analytical subcellular fractionation and enzymic analysis of liver homogenates from control and clofibrate-treated rats, mice and monkeys with reference to the fatty acid-oxidizing enzymes, Ann. N.Y. Acad. Sci., 386:453-455, 1982.
235. Reddy, M. K., Lalwani, N. D., Qureshi, S. A., and Reddy, J. K., Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation associated 80,000 mol. wt. polypeptide by hypolipidemic drugs, Hum. Toxicol., 1:135-147, 1982.
236. Pourbaix, S., Heller, F., and Harvengt, C., Effect of fenofibrate and LF 2151 on hepatic peroxisomes in hamsters, Biochem. Pharmacol., 33:3661-3666, 1984.
237. Gray, R. H. and De la Iglesia, F. A., Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species, Hepatology, 4:520-530, 1984.
238. Eacho, P. I., Foxworthy, P. S., Johnson, W. D., Hoover, D. M., and White, S. L., Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species, Toxicol. Appl. Pharmacol., 83:430-437, 1986.
239. Styles, J. A., Kelly, M., Pritchard, N. R., and Elcombe, C. R., A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyte, Carcinogenesis, 9:1647-1655, 1988.
240. Platt, D. S. and Thorp, J. M., Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate, Biochem. Pharmacol., 15:915-925, 1966.
241. Svoboda, D., Grady, H., and Azarnoff, D., Microbodies in experimentally altered cells, J. Cell Biol., 35:127-152, 1967.
242. Reddy, J. K., Jirtle, R. L., Watanabe, T. K., Reddy, N. K., Michalopoulos, G., and Qureshi, S. A., Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators, Cancer Res., 44:2582-2589, 1984.
243. Jirtle, R. L., Reddy, J. K., and Michalopoulos, G., Induction of peroxisome proliferation in transplanted dog, cat, rat, and human hepatocytes, AACR Abstracts, 25:117, 1984.
244. Hanefeld, M., Kemmer, C., Leonhardt, W., Kunze, K. D., Jaross, W., and Haller, H., Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liver, Atherosclerosis, 36:159-172, 1980.
245. Hanefeld, M., Kemper, C., and Kadner, E., Relationship between morphological changes and lipid-lowering action of p-chlorophenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man, Atherosclerosis, 46:239-246, 1983.
246. De La Iglesia, F. A. L., J. E., Buchanan, R. A., Marcus, E. L., and McMahon, G., Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment, Atherosclerosis, 43:19-37, 1982.
247. Blümcke, S., Schwartzkopff, W., Lobeck, H., Edmondson, N. A., Prentice, D. E., and Blane, G. F., Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients, Atherosclerosis, 46:105-116, 1983.
248. Gariot, P., Barrat, E., Mejean, L., Pointel, J. P., Drouin, P., and Debry, G., Fenofibrate and human liver - lack of proliferation of peroxisomes, Arch. Toxicol., 53:151-163, 1983.
249. Ganning, A. E., Brunk, U., Edlund, C., Elhammer, A., and Dallner, G., Effects of prolonged administration of phthalate ester on the liver, Environ. Health Perspect., 73:251-258, 1987.
250. Hinton, R. H., Price, S. C., and Grasso, P., 1991, as cited in ECETOC: Monograph No. 17, Hepatic peroxisome proliferation, 1992.
251. Ishii, H., Fukumori, N., Horie, S., and Suga, T., Effects of fat content in the diet on hepatic peroxisomes of the rat, Biochim. Biophys. Acta, 617:1-11, 1980.
252. Christiansen, E. N., Flatmark, T., and Kryvi, H., Effects of marine oil diet on peroxisomes and mitochondria of rat liver: a combined biochemical and morphometric study, Eur. J. Cell Biol., 26:11-20, 1981.
253. Bronfman, M., Inestrosa, N. C., and Leighton, F., Fatty acid oxidation by human liver peroxisomes, Biochem. Biophys. Res. Commun., 88:1030-1036, 1979.
254. Büsser, M.-T. and Lutz, W. K., Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters, Carcinogenesis, 8:1433-1437, 1987.
255. Makowska, J. M., Bonner, F. W., and Gibson, G. G., Hepatic induction potency of hypolipidaemic drugs in the rat following long-term administration: influence of different dosing regimens, Xenobiotica, 20:1121-1128, 1990.
256. Kawashima, Y., Hirose, A., Hirose, Y., Adachi, T., and Kozuka, H., Inducing effects of clofibric acid on 1-acylglycerophosphorylcholine acyltransferase in kidney and intestinal mucosa of rats, Biochim. Biophys. Acta, 875:549-553, 1986.
257. Oesch, F., Hartmann, R., Timms, C., Strolin-Benedetti, M., Dostert, P., Wörner, W., and Schladt, L., Time dependence and differential induction of rat and guinea pig peroxisomal β-oxidation, palmitoyl-CoA hydrolase, cytosolic and microsomal epoxide hydrolase after treatment with hypolipidemic drugs, J. Cancer Res. Clin. Oncol., 114:341-346, 1988.
258. Frick, H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., Mäenpää, H., Mälkönen, M., Mänttäri, M., Norola, S., Pasternack, A., Pikkarainen, J., Romo, M., Sjöblom, T., and Nikkiä, E. A., Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle aged men with dyslipidemia, safety of treatment, changes in risk factors and incidence of coronary heart disease, N. Engl. J. Med., 317:1235-1247, 1987.
259. Fitzgerald, J. E., Sanyer, J. L., Schardein, J. L., Lake, R. S., E. J., M., and F. A., D. I. I., Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil, J. Natl. Cancer Inst., 67:1105-1116, 1981.
260. Pill, J., Wolff, S., Stegmeier, K., and Schmidt, F. H., Effect of bezafibrate on serum lipids in normo- and spontaneously hyperlipidemic rats, Methods Find. Exp. Clin. Pharmacol., 10:487-492, 1988.
261. Mitchell, A. M., Bridges, J. W., and Elcombe, C. R., Factors influencing peroxisome proliferation in cultured rat hepatocytes, Arch. Toxicol., 55:239-246, 1984.
262. Garberg, P. and Högberg, J., Selenium metabolism in isolated hepatocytes: inhibition of incorporation in proteins by mono(2-ethylhexyl)phthalate, a metabolite of the peroxisome proliferator di(2-ethylhexyl)-phthalate, Carcinogenesis, 12:7-12, 1991.
263. Foxworthy, P. S. and Eacho, P. I., Conditions influencing the induction of peroxisomal β-oxidation in cultured rat hepatocytes, Toxicol. Lett., 30:189-196, 1986.
264. Feller, D. R. S. Y., Shirhatti, V. R., Kocarek, T. A., Liu, C.-T., and Krisna, G., Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes, Hepatology, 7:508-516, 1987.
265. Muakkassah-Kelly, S. F., Bieri, F., Waechter, F., Bentley, P., and Stäubli, W., Long-term maintenance of hepatocytes in primary culture in the presence of DMSO. Further characterization and effect of nafenopin, a peroxisome proliferator, Exp. Cell Res., 171:37-51, 1987.
266. Tomaszewski, K. E., Heindel, S. W., Jenkins, W. L., and Melnick, R. L., Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures, Toxicology, 65:49-60, 1990.
267. Butterworth, B. E., Smith-Oliver, T., Earle, L., Lowry, J. J., White, R. D., Doolittle, D. J., Working, P. K., Cattley, R. C., Jirtle, R., Michalopoulos, G., and Strom, S. S., Use of primary cultures of human hepatocytes in toxicology studies, Cancer Res., 49:1075-1084, 1989.
268. Gray, T. J. B., Lake, B. G., Beamand, J. A., Foster, J. R., and Gangolli, S. D., Peroxisome proliferation in primary cultures of rat hepatocytes, Toxicol. Appl. Pharmacol., 67:15-25, 1983.
269. Watanabe, T., Okawa, S., Itoga, H., Imanaka, T., and Suga, T., Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators, Biochim. Biophys. Acta, 1135:84-90, 1992.
270. Elcombe, C. R. and Mitchell, A. M., Peroxisome proliferation due to di(2-ethylhexyl)phthalate (DEHP): species differences and possible mechanisms, Environ. Health Perspect., 70:211-219, 1986.
271. Dirven, H. A. A. M., Van den Broek, P. H. H., Peeters, M. C. E., Mennes, W. C., Blaauboer, B. J., Noordhoek, J., and Jongeneelen, F. J., Effects of the peroxisome proliferator mono(2-ethylhexyl)-phthalate in primary hepatocyte cultures derived from rat, guinea pig, rabbit and monkey. Relationship between interspecies differences in biotransformation and peroxisome proliferating potencies, Biochem. Pharmacol., 45:2425-2434, 1993.
272. Garberg, P. and Högberg, J., Studies on Se incorporation in selenoproteins; effects of peroxisome proliferators and hydrogen peroxide generating system, Chem. Biol. Interact., 81:291-306, 1992.
273. Lake, B. G., Gray, T. J. B., Pels-Rijcken, W. R., Beamand, J. A., and Gangolli, S. D., The effect of hypolipidemic agents on peroxisomal β-oxidation and mixed function oxidase activities in primary cultures of rat hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and lauric acid hydroxylation, Xenobiotica, 14:269-276, 1984.
274. Gray, T. J. B., Beamand, J. A., Lake, B. G., Foster, J. R., and Gangolli, S. D., Peroxisome proliferation in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolites, Toxicol. Lett., 10:273-279, 1982.
275. Lake, B. G., Lewis, D. F. V., Gray, T. J. B., and Beamand, J. A., Structure-activity relationship for induction of peroxisomal enzyme activities in primary rat hepatocyte cultures, Toxicol. in Vitro, 7:605-614, 1993.
276. Bieri, F., Muakkassah-Kelly, S., Waechter, F., and Stäubli, W., Use of primary cultures of adult rat hepatocytes to study the mode of action of the peroxisome proliferator nafenopin, in Peroxisomes in Biology and Medicine, Fahimi, H. D. and Sies, H., Eds., Springer-Verlag, Berlin, Heidelberg, 286-294, 1986.
277. Bieri, F., Bentley, P., Waechter, F., and Stäubli, W., Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nefenopin, a hepatocarcinogenic peroxisome proliferator, Carcinogenesis, 5:1033-1039, 1984.
278. Muakassah-Kelly, S. F., Bieri, F., Waechter, F., Bentley, P., and Stäubli, W., The use of primary cultures of adult rat hepatocytes to study induction of enzymes and DNA synthesis: effect of nafenopin and electroporation, Experientia, 44:823-827, 1988.
279. Bichet, N., Cahard, D., Fabre, G., Remandet, B. D. G., and Cano, J. P., Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture, Toxicol. Appl. Pharmacol., 106:509-517, 1990.
280. Mitchell, A. M., Lhuguenot, J. C., Bridges, J. W., and Elcombe, C. R., Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl)phthalate, Toxicol. Appl. Pharmacol., 80:23-32, 1985.
281. Allen, K. L., Green, C. E., and Tyson, C. A., Comparative studies of peroxisomal enzyme induction in hepatocytes from rat, cynomolgus monkey and human by hypolipidemic drugs (Abstract), Toxicologist, 7:253, 1987.
282. Blaauboer, B. J., van Holsteijn, C. W. M., Bleumink, R., Mennes, W. C., van Pelt, F. N. M. A., Yap, S. H., van Pelt, J. F., van Iersel, A. A. J., Timmerman, A., and Schmid, B. P., The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes, Biochem. Pharmacol., 40:521-528, 1990.
283. Parzefall, W., Erber, E., Sedivy, R., and Schulte-Hermann, R., Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters, Cancer Res., 51:1143-1147, 1991.
284. Mikalsen, S. O., Holen, I., and Sanner, T., Morphological transformation and catalase activity of Syrian hamster embryo cells treated with hepatic peroxisome proliferators, TPA and nickel sulphate, Cell Biol. Toxicol., 6:1-13, 1990.
285. Mikalsen, S.-O., Ruyter, B., and Sanner, T., Effects of hepatic peroxisome proliferators and 12-O-tetradecanoyl phorbol-13-acetate on catalase and other enzyme activities of embryonic cells in vitro, Biochem. Pharmacol., 39:527-535, 1990.
286. Phillips, B. J., Anderson, D., and Gangolli, S. D., Studies on the genetic effects of phthalic acid esters on cells in culture, Environ. Health Perspect., 65:263-266, 1986.
287. Glauert, H. P., Hennig, B., and Chow, H. S., Induction of peroxisomal enzymes in cultured porcine endothelial cells by the hypolipidemic drug ciprofibrate, J. Biochem. Toxicol., 5:115-118, 1990.
288. Berg, R. K. and Lillehaug, J. R., Tiadenol-mediated induction of peroxisomal enzymes in cultured C3H/ 10T1/2CL8 cells and in chemically transformed C3H/ 10T1/2MCA16 cells, Int. J. Cancer, 36:489-494, 1985.
289. Lillehaug, J. R. and Berge, R. K., The tumour promoter 12-O-tetradecanoylphorbol-13-acetate increases the activities of some peroxisome associated enzymes in in vitro cell culture, Br. J. Cancer, 53:121-127, 1986.
290. Lhuguenot, J.-C., Mitchell, A. M., Milner, G., Lock, E. A., and Elcombe, C. R., The metabolism of di(2-ethylhexyl)phthalate (DEHP) and mono(2-ethylhexyl) phthalate (MEHP) in rats: in vivo and in vitro dose and time dependency of metabolism, Toxicol. Appl. Pharmacol., 80:11-22, 1985.
291. Cornu, M. C., Lhuguenot, J. C., Brady, A. M., Moore, R., and Elcombe, C. R., Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl) adipate and species differences in response, Biochem. Pharmacol., 43:2129-2134, 1992.
292. Behrens, M. I., Soza, M. A., and Inestrosa, N. C., Increase of muscle peroxisomal enzymes and myotonia induced by nafenopin, a hypolipidemic drug, Muscle Nerve, 6:154-159, 1983.
293. Sharma, R. K., Lake, B. G., Makowski, R., Bradshaw, T., Earnshaw, D., Dale, J. W., and Gibson, G. G., Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney, characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation, Eur. J. Biochem., 184:69-78, 1989.
294. Nemali, M. R., Usuda, N., Reddy, M. K., Oyasu, K., Hashimoto, T., Osumi, T., Rao, M. S., and Reddy, J. K., Comparison of constitutive and inducible levels of expression of peroxisomal β-oxidation and catalase genes in liver and extrahepatic tissue of rat, Cancer Res., 48:5316-5324, 1988.
295. Vamecq, J. and Draye, J.-P., Peroxisomal and mitochondrial β-oxidation of monocarboxylyl-CoA, omega-hydroxymonocarboxylyl-CoA and dicarboxylyl-CoA esters in tissues from untreated and clofibrate-treated rats, J. Biochem., 106:216-222, 1989.
296. Mittal, B. and Kurup, C. K. R., Induction of carnitine acetyltransferase by clofibrate in rat liver, Biochem. J., 194:249-255, 1981.
297. Veerkamp, J. H. and van Moerkerk, H. T. B., Peroxisomal fatty acid oxidation in rat and human tissues. Effect of nutritional state, clofibrate treatment and postnatal development in the rat, Biochim. Biophys. Acta, 875:301-310, 1986.
298. Katoh, H., Kawashima, Y., Watanuki, H., Kozuka, H., and Isono, H., Effects of clofibric acid and tiadenol on cytosolic long-chain acyl-CoA hydrolase and peroxisomal β-oxidation in liver and extrahepatic tissues of rats, Biochim. Biophys. Acta, 920:171-179, 1987.
299. Yamada, J., Sakuma, M., and Suga, T., Assay of fatty acid omega-hydroxylation using high-performance liquid chromatography with fluorescence labeling reagent, 3-bromomethyl-7-methoxy-1,4-benzoaxin-2-one (BrMB), Anal. Biochem., 199: 132-136, 1991.
300. Lalwani, N. D., Reddy, M. K., Mangkornkanok-Mark, M., and Reddy, J. K., Induction, immunochemical identity and immunofluorescence localization of an 80,000-molecular-weight peroxisome-proliferation-associated polypeptide (polypeptide PPA-80) and peroxisomal enoyl-CoA hydratase of mouse liver and renal cortex, Biochem. J., 198:177-186, 1981.
301. Reddy, J. K., Warren, J. R., Reddy, M. K., and Lalwani, N. D., Hepatic and renal effects of peroxisome proliferators: biological implications, Ann. N.Y. Acad. Sci., 386:81-110, 1982.
302. Hawkins, J. M., Jones, W. E., Bonner, F. W., and Gibson, G. G., The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney, Drug Metab. Rev., 18:441-515, 1987.
303. Ohno, H., Peroxisomes of the kidney, Int. Rev. Cytol., 95:131-162, 1985.
304. Zaar, K., Structure and function of peroxisomes in the mammalian kidney, Eur. J. Cell Biol., 59:233-254, 1992.
305. van Veldhoven, P. and Mannaerts, G. P., Comparison of the activities of some peroxisomal and extraperoxisomal lipid-metabolizing enzymes in liver and extrahepatic tissues of the rat, Biochem. J., 227:737-741, 1985.
306. Takagi, A., Sai, K., Umemura, T., Hasegawa, R., and Kurokawa, Y., Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats, Cancer Lett., 57:55-60, 1991.
307. Walusimbi-Kisutu, M. and E. H., H., Fluorimetric assay for rat liver peroxisomal fatty acyl-coenzyme A oxidase activity, J. Lipid Res., 24:1077-1084, 1983.
308. MacDonald, R. S. and Swan, P. B., The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle, Biochim. Biophys. Acta, 880:153-160, 1986.
309. Glatz, J. F. C., Wagenmakers, J. M., Veerkamp, J. H., and van Moerkerk, H. T. B., Effect of clofibrate feeding on palmitate and branched-chain 2-oxo acid oxidation in rat liver and muscle, Biochem. Pharmacol., 32:2489-2493, 1983.
310. Norseth, J. and Thomassen, M. S., Stimulation of microperoxisomal β-oxidation in rat heart by high-fat diets, Biochim. Biophys. Acta, 751:312-320, 1983.
311. Kremser, K., Schön, H. J., Lohninger, A., Prager, C. M., Kramar, R., and Böck, P., Response to thyroxine of lamellar bodies, peroxisomes and peroxisomal enzymes in the adult rat lung, Eur. J. Clin. Chem. Clin. Biochem., 29:151-158, 1991.
312. Osumi, T. and Hashimoto, T., The inducible fatty acid oxidation system in mammalian peroxisomes, Trends Biochem. Sci., 317-319, 1984.
313. Fringes, B. and Reith, A., Time course of peroxisome biogenesis during adaptation to mild hyperthyroidism in rat liver, Lab. Invest., 47:19-26, 1982.
314. Rao, M. S., Lalwani, N. D., Watanabe, T. K., and Reddy, J. K., Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisomal proliferator, Cancer Res., 44:1072-1076, 1984.
315. Rao, M. S., Scarpelli, D. G., and Reddy, J. K., Transdifferentiated hepatocytes in rat pancreas, Curr. Top. Dev. Biol., 20:63-78, 1986.
316. Lalwani, N. D., Reddy, M. K., Qureshi, S. A., and Reddy, J. K., Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio)acetic acid (WY-14,643) in the semipurified diet, Carcinogenesis, 2:645-650, 1981.
317. Rao, M. S., Reddy, M. K., and Reddy, J. K., Response of chemically induced hepatocyte-like cells in hamster pancreas to methyl clofenapate, a peroxisome proliferator, J. Cell Biol., 95:50-56, 1982.
318. Reddy, J. K., Goel, S. K., Nemali, M. R., Carrino, J. J., Laffler, T. G., Reddy, M. K., Sperbeck, S. J., Osumi, T., Hashimoto, T., Lalwani, N. D., and Rao, M. S., Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators, Proc. Natl. Acad. Sci. U.S.A., 83:1747-1751, 1986.
319. Nemali, M. R., Reddy, M. K., Usuda, N., Reddy, P. G., Corneau, L. D., Rao, M. S., and Reddy, J. K., Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens, Toxicol. Appl. Pharmacol., 97:72-87, 1989.
320. Fukami, M. H., Eikholm, T. S., Ekanger, R., Flatmark, T. and Nilsson, A., Relation between induction of ornithin decarboxylase and specific gene expression in rat liver in response to the promoter agent clofibrate, Carcinogenesis, 7:1441-1446, 1986.
321. McQuaid, S., Russel, S. E. H., White, S. A., Pearson, C. M., Elcombe, C. R., and Humphries, P., Analysis of transcripts homologous to acyl-CoA oxidase and enoyl-CoA-hydratase 3-hydroxyacyl-CoA dehydrogenase induced rat liver by methylclofenapate, Cancer Lett., 37:115-121, 1987.
322. Bell, D. R., Plant, N. J., Rider, C. G., Na, L., Brown, S., Ateitalla, I., Acharya, S. K., Davies, M. H., Elias, E., Jenkins, N. A., Gilbert, D. A., Copeland, N. G., and Elcombe, C. R., Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4a cDNAs, Biochem. J., 294:173-180, 1993.
323. Hardwick, J., Song, B. J., Huberman, E., and Gonzalez, F. J., Isolation, complementary DNA-sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450 LA omega). Identification of a new
324. Bieri, F., Nemali, M. R., Muakassah-Kelly, S., Weachter, F., Stäubli, W., Reddy, J. K., and Bentley, P., Increased peroxisomal enzyme mRNA levels in adult rat hepatocytes cultured in a chemically defined medium and treated with nafenopin, Toxicol. in Vitro. 2:235-240, 1988.
325. Gibson, G. G., Comparative aspects of the mammalian cytochrome P450 IV gene family, Xenobiotica, 10:1123-1148, 1989.
326. Roman, L. J., Palmer, C. N., Clark, J. E., Muerhoff, A. S., Griffin, K. J., Johnson, E. F., and Masters, B. S., Expression of rabbit cytochromes P4504A which catalyze the omega-hydroxylation of arachidonic acid, fatty acids, and prostaglandins, Arch. Biochem. Biophys., 307:57-65, 1993.
327. Furuta, S., Miyazawa, S., and Hashimoto, T., Biosynthesis of enzymes of peroxisomal β-oxidation, J. Biochem., 92:319-326, 1982.
328. Bell, C. R. and Elcombe, C. R., Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators, Biochem. J., 280:249-253, 1991.
329. Thangada, S., Alvares, K., Mangino, M., Usman, M. I., Rao, M. S., and Reddy, J. K., An in vitro demonstration of peroxisome proliferation and increase in peroxisomal β-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate, FEBS Lett., 250:205-210, 1989.
330. Chaterjee, B., Murty, C. V. R., Olson, M. J., and Roy, A. K., Cloning and expression of the rat liver cDNA for peroxisomal enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase in lambda-GT11. Transcriptional regulation of enzyme activity by WY-14,643 in primary cultures of rat hepatocytes, Eur. J. Biochem., 166:273-278, 1987.
331. Shaffer, C. B., Carpenter, C. P., and Smyth, H. F., Jr., Acute and subacute toxicity of di(2-ethylhexyl)-phthalate with note upon its metabolism, J. Ind. Hyg. Toxicol., 27:130-135, 1945.
332. Gray, T. J. B., Butterworth, K. R., Gaunt, I. F., Grasso, P., and Gangolli, S. D., Short-term toxicity study of di(2-ethylhexyl)phthalate in rats, Food Cosmet. Toxicol., 15:389-399, 1977.
333. Krauskopf, L. G., Studies on the toxicity of phthalate via ingestion, Environ. Health Perspect., 3:61-72, 1973.
334. Singh, A. R., Lawrence, W. H., and Autian, J., Teratogenicity of phthalate esters in rat, J. Pharm. Sci., 61:51-55, 1972.
335. Lawrence, W. H., Malik, M., Turner, J. E., Singh, A. R., and Autian, J., A toxicological investigation of some acute, short-term, and chronic effects of administering di-2-ethylhexyl phthalate (DEHP) and other phthalate esters, Environ. Res., 9:1-11, 1975.
336. Calley, D., Autian, J., and Gues, W. L., Toxicology of a series of phthalate esters, J. Pharm. Sci., 55:158-162, 1966.
337. Harris, R. S., Hodge, H. C., Maynard, E. A., and Blanchet, H. J. J., Chronic oral toxicity of 2-ethylhexyl-phthalate in rats and dogs, Arch. Ind. Health, 13:259-264, 1956.
338. Carpenter, C. P., Weil, C. S., and Smith, H. F. J., Chronic oral toxicity of di(2-ethylhexyl)phthalate for rats, guinea pigs, and dogs, Am. Med. Assoc. Arch. Ind. Hyg. Occup. Med., 8:219-226, 1953.
339. Röckel, A., Klinke, B., Hertel, J., Bauer, X., Thiel, C., Abdelhamid, S., Fiegel, P., and Walb, D., Allergy to dialysis materials, Nephrol. Dial. Transplant., 4:646-652, 1989.
340. Lamb, J. C., Chapin, R. E., Teague, J., Lawton, A. D., and Reel, J. R., Reproductive effects of four phthalic acid esters in the mouse, Toxicol. Appl. Pharmacol., 88:255-269, 1987.
341. Agarwal, D. K., Lawrence, W. H., Turner, J. E., and Autian, J., Effects of parenteral di(2-ethylhexyl)-phthalate (DEHP) on gonadal biochemistry, pathology, and reproductive performance of mice, J. Toxicol. Environ. Health, 26:39-59, 1989.
342. Nikonorow, M., Mazur, H., and Peikacz, H., Effect of orally administered plasticizers and polyvinyl chloride stabilizers in the rat, Toxicol. Appl. Pharmacol., 26:253-259, 1973.
343. Yagi, Y., Nakamura, Y., Tomita, I., Tsuchikawa, K., and Shimoi, N., Teratogenic potential of di- and mono-2-ethylhexylphthalate in mice, J. Environ. Pathol. Toxicol., 4:533-544, 1980.
344. Tomita, I., Nakamura, Y., Yagi, Y., and Tutikawa, K., Teratogenicity/fetotoxicity of DEHP in mice, Environ. Health Perspect., 45:71-75, 1982.
345. Tyl, R. W., Price, C. J., Marr, M. C., and Kimmel, C. A., Developmental toxicity evaluation of dietary di(2-ethylhexyl)phthalate in Fischer 344 rats and CD-1 mice, Fundum. Appl. Toxicol., 10:395-412, 1988.
346. Thomas, J. A., Schein, L. G., Gupta, P. K., McCafferty, R. E., Felice, P. R., and Donovan, M. P., Failure of mono-ethylhexyl phthalate to cause teratogenic effects in offspring of rabbits, Toxicol. Appl. Pharmacol., 51:523-528, 1979.
347. Shiota, K. and Mima, S., Assessment of the teratogenicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in mice, Arch. Toxicol., 56:263-266, 1985.
348. Faustmann, E. M., Wellington, D. G., Smith, W. P., and Kimmel, C. A., Characterization of a developmental toxicity dose-response model, Environ. Health Perspect., 79:229-241, 1989.
349. McDonald, A. D., Lavoie, J., Cote, R., and McDonald, J. C., Spontaneous abortion in women employed in plastics manufacture, Am. J. Ind. Med., 14:9-14, 1988.
350. Gray, T. J. B. and Gangolli, S., Aspects of the testicular toxicity of phthalate esters, Environ. Health Perspect., 65:229-235, 1986.
351. Gray, T. J. B. and Butterworth, K. R., Testicular atrophy produced by phthalate esters, Arch. Toxicol., Suppl. 4:452-455, 1980.
352. Curto, K. A. and Thomas, J. A., Comparative effects of diethylhexyl phthalate or monoethylhexyl phthalate on male mouse and rat reproductive organs, Toxicol. Appl. Pharmacol., 62:121-125, 1982.
353. Oishi, S., Testicular atrophy induced by di(2-ethylhexyl)phthalate: changes in histology, cell specific enzyme activities and zinc concentrations in rat testis, Arch. Toxicol., 59:290-295, 1986.
354. Seth, P. K., Srivastava, S. P., Agarwal, D. K., and Chandra, S. V., Effect of di-2-ethylhexyl phthalate (DEHP) on rat gonads, Environ. Res., 12:131-138, 1976.
355. Siddiqui, A. and Srivastava, S. P., Effect of di(2-ethylhexyl)phthalate on rat sperm count and on sperm metabolic enzymes, Bull. Environ. Contain. Toxicol., 48:115-119, 1992.
356. Oishi, S. and Higara, K., Testicular atrophy induced by di-(2-ethylhexyl)phthalate. Effect of zinc supplement, Toxicol. Appl. Pharmacol., 70:43-48, 1983.
357. Oishi, S. and Hiraga, K., Testicular atrophy induced by phthalic acid monoesters: effects of zinc and testosterone concentrations, Toxicology, 15:197-202, 1980.
358. Oishi, S. and Hiraga, K., Testicular atrophy induced by phthalic acid esters: effect on testosterone and zinc concentrations, Toxicol. Appl. Pharmacol., 53:35-41, 1980.
359. Gangolli, S. D., Testicular effects of phthalate esters, Environ. Health Perspect., 45:77-84, 1982.
360. Gray, T. J. B., Rowland, I. R., Foster, P. M. D., and Gangolli, S. D., Species differences in the testicular toxicity of phthalate esters, Toxicol. Lett., 11:141-147, 1982.
361. Jones, H. B., Garside, D. A., Liu, R., and Roberts, J. C., The influence of phthalate esters on Leydig cell structure and function in vitro and in vivo, Exp. Mol. Pathol., 58:179-193, 1993.
362. Srivastava, S. and Srivastava, S. P., Effect of di(2-ethylhexyl)phthalate on 17β-hydroxy steroid dehydrogenase activity in testis of rat, Toxicol. Lett., 57:235-239, 1991.
363. Oishi, S. and Hiraga, K., Effects of phthalic acid monoesters on mouse testes, Toxicol. Lett., 6:239-242, 1980.
364. Oishi, S. and Hiraga, K., Effect of phthalic acid esters on mouse testes. Testicular atrophy induced by phthalic acid monoesters: effects of zinc and testosterone concentrations, Toxicol. Lett., 5:413-416, 1980.
365. Oishi, S., Strain differences in susceptibility to di-2-ethylhexyl phthalate-induced testicular atrophy in mice, Toxicol. Lett., 66:47-52, 1993.
366. Rhodes, C., Elcombe, C. R., Batten, P. L., Bratt, H., Jackson, S. J., Pratt, I. S., and Orton, I. C., Comparative toxicity of di-(2-ethylhexyl)phthalate (DEHP) in rats and marmosets, Toxicol. Lett., 18 Suppl. 1:63, 1983.
367. Crocker, J. F. S., Safe, S. H., and Acott, P., Effect of chronic phthalate exposure on the kidney, J. Toxicol. Environ. Health, 23:433-444, 1988.
368. Woodward, K. N., Phthalate esters, cystic kidney disease in animals and possible effect on human health: a review, Hum. Exp. Toxicol., 9:397-401, 1990.
369. Gaunt, J. F., Colley, J., Grasso, P., and Landsdown, A. B. G., Acute (rat and mouse) and short-term (rat) toxicity study on dialkyl 7+9 phthalate (a mixture of phthalate esters of alcohols having 7-9 carbon atoms), Food Cosmet. Toxicol., 6:609-618, 1968.
370. Omori, Y., Recent progress in safety evaluation studies on plasticizers and plastics and their controlled use in Japan, Environ. Health Perspect., 17:203-209, 1976.
371. Schulz, C. O., Rubin, R. J., and Hutchins, G. M., Acute lung toxicity and sudden death in rats following the intravenous administration of the plasticizer, di(2-ethylhexyl)-phthalate, solubilized with Tween surfactants, Toxicol. Appl. Pharmacol., 33:514, 1975.
372. Rubin, R. J. and Chang, J. C. F., Effect of the intravenous administration of the solubilized plasticizer, di(2-ethylhexyl) phthalate on the lung and on survival of transfused rats (abstract), Toxicol. Appl. Pharmacol., 45:230, 1978.
373. Klimisch, H. J., Gamer, A. O., Hellwig, J., Kaufmann, W., and Jäckh, R., Di-(2-ethylhexyl) phthalate: a short-term repeated inhalation toxicity study including fertility assessment, Food Chem. Toxicol., 30:915-919, 1992.
374. Doelman, C. J. A., Borm, P. J. A., and Bast, A., Plasticizers, another burden for asthmatics? Agents Actions, Suppl. 31:81-84, 1990.
375. Doelman, C. J. A., Borm, P. J. A., and Bast, A., Plasticizers and bronchial hyperreactivity, Lancet, 335:725, 1990.
376. Labow, R. S., Barry, Y. A., Tocchi, M., and Keon, W. J., The effect of mono(2-ethylhexyl)phthalate on an isolated perfused rat heart-lung preparation, Environ. Health Perspect., 89:189-193, 1990.
377. Barry, Y. A., Labow, R. S., Rock, G., and Keon, W. J., Cardiotoxic effects of the plasticizer metabolite, mono(2-ethylhexyl)phthalate (MEHP), on human myocardium, Blood, 72:1438-1439, 1988.
378. Fassett, D. W., Esters. In: Patty, F. A., Ed., Industrial Hygiene and Toxicology, 2nd rev. ed., New York: Interscience, 1904-1907, 1963.
379. Tobe, M., Suzuki, Y., Ikeda, Y., and Naito, K., A study on toxicity of phthalates and adipate. Chronic toxicity test in mice, FDA FAP No. 1T3573:010623-010676, 1984.
380. Rao, M. S., Usuda, N., Subbarao, V., and Reddy, J. K., Absence of gamma-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator, Carcinogenesis, 8:1347-1350, 1987.
381. Ganning, A. E., 1987, quoted in: Stephen Hsia, M. T., The Relationship between carcinogenesis and peroxisome proliferation in rodent liver after exposure to the plasticizer DEHP and DEHA, Mitre Corporation, McLean, VA, 1990.
382. Tamura, H., Iida, T., Watanabe, T., and Suga, T., Lack of induction of hepatic DNA-damage on long-term administration of peroxisome proliferators in male F-344 rats, Toxicology, 69:55-62, 1991.
383. Schmezer, P., Pool, B. L., Klein, R. G., Komitowski, D., and Schmahl, D., Various short-term assays and two long-term studies with the plasticizer di(2-ethylhexyl)phthalate in the Syrian Golden hamster, Carcinogenesis, 9:37-43, 1988.
384. Parzefall, W., Schuppler, J., Barthel, G., Meyer-Rogge, B., and Schulte-Hermann, R., Toxicological studies on a benzofurane derivative. I. A comparative study with phenobarbital on rat liver, Toxicol. Appl. Pharmacol., 106:482-499, 1990.
385. Kraupp-Grasl, B., Huber, W., Taper, H., and Schulte-Hermann, R., Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously, Cancer Res., 51:666-671, 1991.
386. Goodman, D. G., Ward, J. M., Squire, R. A., and Chu, K. C., Neoplastic and nonneoplastic lesions in aging F344 rats, Toxicol. Appl. Pharmacol., 48:237-248, 1979.
387. NTP, National Toxicology Program: Carcinogenesis bioassay of di(2-ethylhexyl)adipate (CAS No. 103-23-1) in F344 rats and B6C3F1 mice (feed study). Tech. Rep. Series, 212, 1982.
388. Svoboda, D. J. and Azarnoff, D. L., Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug, Cancer Res., 39:3419-3428, 1979.
389. Reddy, J. K. and Qureshi, S. A., Tumorigenicity of the hypolipidemic peroxisome proliferator ethyl-a-p-chlorophenoxyisobutyrate (clofibrate) in rats, Br. J. Cancer, 40:476-482, 1979.
390. Reddy, J. K. and M. S., R., Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator, J. Natl. Cancer Inst., 59:1645-1650, 1977.
391. Kraupp-Grasl, B., Huber, W., Putz, B., Gerbracht, U., and Schulte-Hermann, R., Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver, Cancer Res., 50:3701-3708, 1990.
392. Rao, M. S., Lalwani, N. D., and Reddy, J. K., Sequential histologic study of rat liver during peroxisome proliferator (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio)acetic acid (WY-14,643)-induced carcinogenesis, J. Natl. Cancer Inst., 73:983-990, 1984.
393. Reddy, J. K., M. S., R., Azarnoff, D. L., and Sell, S., Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferation, (4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio)acetic acid (WY-14,643) in rat and mouse liver, Cancer Res., 39:152-161, 1979.
394. Kluwe, W. M., Huff, J. E., Matthews, H. B., Irwin, R., and Haseman, J. K., Comparative chronic toxicities and carcinogenic potentials of 2-ethylhexyl-containing compounds in rats and mice, Carcinogenesis, 6:1577-1583, 1985.
395. Kluwe, W. M., McConnell, E. E., Huff, J. E., Haseman, J. K., Douglas, J. F., and Hartwell, W. V., Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute, Environ. Health Perspect., 45:129-133, 1982.
396. Exxon Corporation, Chronic toxicity/carcinogenicity study of diisononyl phthalate (DINP) in the rat. Research and Environmental Health Division, Exxon Corporation, Baton Rouge, LA, 1986.
397. IPCS-study, International Programme on Chemical Safety, Evaluation of short-term tests for carcinogens. Report of the international programme on chemical safety's collaborative study on in vitro assays, Ashby, J., de Serres, F. J., Draper, M., Ishidate, M., Margolin, B. H., Matter, B. E., Shelby, M. D., Eds. Progress in Mutation Research, 1985; 5, 1-752.
398. Simmon, V. F., Kauhanen, K., and Tardiff, R. G., Mutagenic activity of chemicals identified in drinking water, Dev. Toxicol. Environ. Sci., 2:249-258, 1977.
399. Ruddick, J. A., Villeneuve, D. C., Chu, I., Nestman, E., and Miles, D., An assessment of the teratogenicity in the rat and mutagenicity in Salmonella of mono-(2-ethylhexyl)phthalate, Bull. Environ. Contam. Toxicol., 27:181-186, 1981.
400. Kozumbo, W. J., Kroll, R., and Rubin, R. J., Assessment of the mutagenicity of phthalate esters, Environ. Health Perspect., 45:103-109, 1982.
401. Kirby, P. E., Pizzarello, R. F., Lawlor, T. E., Haworth, S. R., and Hodgson, J. R., Evaluation of di(2-ethylhexyl)phthalate and its major metabolites in the Ames test and L5178Y mouse lymphoma mutagenicity assay, Environ. Mutagen., 5:657-663, 1983.
402. Barber, E. D., Mulholland, A., Jagannath, D. R., Cifone, M., Cimino. M., Myhr, B., and Rundell, J., The testing of di(2-ethylhexyl)phthalate (DEHP), mono(2-ethylhexyl)phthalate (MEHP), di(2-ethylhexyl)adipate (DEHA), and 2-ethylhexanol (2-EH) in a battery of genotoxicity assays, Paper presented at the Society of Toxicology Meeting, 1985.
403. Tennant, R. W., B. H., M., Shelby, M. D., Zeiger, E., Haseman, J. K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R., Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays, Science, 236:933-940, 1987.
404. Tomita, I., Nakamura, Y., Aoki, N., and Inui, N., Mutagenic/carcinogenic potential of DEHP and MEHP, Environ. Health Perspect., 45:119-125, 1982.
405. Seed, J. L., Mutagenic activity of phthalate esters in bacterial liquid suspension assays, Environ. Health Perspect., 45:111-114, 1982.
406. Yoon, J. S., Mason, J. M., Valencia, R., Woodruff, R. C., and Zimmering, S., Chemical mutagenesis testing in Drosophila. IV. Results of 45 coded compounds tested for the National Toxicology Program, Environ. Mutagen., 7:349-367, 1985.
407. Hodgson, J. R., Myhr, B. C., McKeon, M., and Brusick, D. J., Evaluation of di(2-ethylhexyl)phthalate and its major metabolites in the primary rat hepatocyte unscheduled DNA synthesis assay, Environ. Mutagen., 4:388, 1982.
408. Kornbrust, D. J., Barfknecht, T. R., Ingram, P., and Shelburne, J. D., Effect of di(2-ethylhexyl)-phthalate on DNA repair and lipid peroxidation in rat hepatocytes and on metabolic cooperation in Chinese hamster V-79 cells, J. Toxicol. Environ. Health, 13:99-116, 1984.
409. Abe, S. and Sasaki, M., Chromosome aberrations and sister chromatid exchanges in Chinese hamster cells exposed to various chemicals, J. Natl. Cancer Inst., 58:1635-1641, 1977.
410. Phillips, B. J., James, T. E. B., and Gangolli, S. D., Genotoxicity studies of di(2-ethylhexyl)phthalate and its metabolites in CHO cells, Mutat. Res., 102:297-304, 1982.
411. Turner, J. H., Petricciani, J. C., Crouch, M. L., and Wenger, S., An evaluation of the effects of diethylhexyl-phthalate (DEHP) on mitotically capable cells in blood packs, Transfusion, 14:560, 1974.
412. Stenchever, M. A., Allen, M. A., Jerominski, L., and Petersen, R. V., Effects of bis(2-ethyl hexyl)phthalate on chromosomes of human leukocytes and human fetal lung cells, J. Pharm. Sci., 65:1648-1651, 1976.
413. Tsuchiya, K. and Hattori, K., Chromosomal study on human leukocyte cultures treated with phthalate acid esters (Jpn.), Hoeka, 26:114, 1976.
414. Sanchez, J. H., Abernethy, D. J., and Boreiko, C. J., Lack of di-(2-ethylhexyl)phthalate activity in the C3H/10T1/2 cell transformation system, Toxic. In Vitro, 1:49-53, 1987.
415. CMA, Chemical Manufacturers Association, Phthalate Esters Program Panel, Voluntary Test Program. Health Effects Testing, Phase 1: Validation Results, Cox, G. V. and Moran, E. J., Eds., CMA, Washington, D.C., 1982, 1.
416. Astill, B., Barber, E., Lington, A., Moran, E., Mulholland, A., Robinson, E., and Schneider, B., Chemical industry voluntary test program for phthalate esters: health effect studies, Environ. Health Perspect., 65:329-336, 1986.
417. Diwan, B. A., Ward, J. M., Rice, J. M., Colburn, N. H., and Spangler, E. F., Tumor-promoting effects of di(2-ethylhexyl)phthalate in JB6 mouse epidermal cells and mouse skin, Carcinogenesis, 6:343-347, 1985.
418. Malcolm, A. R., Mills, L. J., and McKenna, E. J., Inhibition of metabolic cooperation between Chinese hamster V79 cells by (tumor promoters and other chemicals), Ann. N.Y. Acad. Sci., 407:448, 1983.
419. Malcolm, A. R. and Mills, L. J., Inhibition of gap-junctional intercellular communication between Chinese hamster lung fibroblasts by di(2-ethylhexyl) phthalate (DEHP) and trisodium nitrilotriacetate monohydrate (NTA), Cell. Biol. Toxicol., 5:145-153, 1989.
420. Klaunig, J. E., Ruch, R. J., De Angelo, A. B., and Kaylor, W. H., Inhibition of mouse hepatocyte intercellular communication by phthalate monoesters, Cancer Lett., 43:65-71, 1988.
421. Malcolm, A. R., Mutagenicity and tumor-promoting potential of di-(2-ethylhexyl)phthalate in Chinese hamster cells. United States Environmental Protection Agency, Environmental Research Laboratory, Narragansett, R.I., Draft, 1982.
422. Von Däniken, A., Lutz, W. W., Jäckh, R., and Schlatter, C., Investigation of the potential of binding of di-(2-ethylhexyl)phthalate and di-(2-ethylhexyl)adipate to liver DNA in vivo, Toxicol. Appl. Pharmacol., 73:373-387, 1984.
423. Gupta, R. C., Goel, S. K., Earley, K., Singh, B., and Reddy, J. K., 32P-Postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro, Carcinogenesis, 6:933-936, 1985.
424. Lutz, W. K., Investigation of the potential for binding of di(2-ethylhexyl)phthalate (DEHP) to rat liver DNA in vivo, Environ. Health Perspect., 65:267-269, 1986.
425. Elliott, B. M. and Elcombe, C. R., Effects of reactive oxygen species produced by peroxisome proliferation in the livers of rats, Proc. Am. Assoc. Cancer Res., 26:72, 1985.
426. Takagi, A. S. K., Umemura, T., Hasegawa, R., and Kurokawa, Y., Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators: di(2-ethylhexyl)phthalate, aluminium clofibrate and simfibrate, Cancer Lett., 53:33-38, 1990.
427. Cattley, R. C. and Glover, S. E., Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization, Carcinogenesis, 14:2495-2499, 1993.
428. Putman, D. L., Moore, W. A., M., S. L., and Hodgson, J. R., Cytogenetic evaluation of di(2-ethylhexyl)phthalate and its major metabolites in Fischer 344 rats, Environ. Mutagen., 5:227, 1983.
429. Hamano, Y., Inoue, K., Oda, Y., Yamamoto, H., and Kunita, N., Studies on toxicity of phthalic acid esters. 2. Dominant lethal test of DEHP and MEHP in mice, Toxicology, 92:145, 1980.
430. Rushbrook, C. J., A., J. T., and Hodgson, J. R., Dominant lethal study of di-(2-ethylhexyl)phthalate and its major metabolites in ICR/SIM mice (Abstract), Environ. Mutagen., 5:387, 1982.
431. Singh, A. R., Lawrence, W. H., and Autian, J., Mutagenic and antifertility sensitivities of mice to di(2-ethylhexyl)phthalate (DEHP) and dimethoxyethyl phthalate (DMEP), Toxicol. Appl. Pharmacol., 29:35-46, 1974.
432. Autian, J., Antifertility effects and dominant lethal assays for mutagenic effects of DEHP, Environ. Health Perspect., 45:115-118, 1982.
433. Douglas, R. G., Hugenholtz, A. P., and Blakey, D. H., Genetic toxicology of phthalate esters: mutagenic and genotoxic effects, Environ. Health Perspect., 65:255-262, 1986.
434. Adler, I. D. and Ashby, J., The present lack of evidence for unique rodent germ-cell mutagens, Mutat. Res., 212:55-66, 1989.
435. Kasai, H., Okada, Y., Nishimura, S., Rao, M. S., and Reddy, J. K., Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator, Cancer Res., 49:2603-2605, 1989.
436. Hegi, M. E., Ulrich, D., Sagelsdorff, P., Richter, C., and Lutz, W. K., No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet, Mutat. Res., 238:325-329, 1990.
437. Denda, A. S. K., Tang, Q., Tsujiuchi, T., Tsutsumi, M., Amanuma, T., Murata, Y., Nakae, D., Maruyama, H., Kurokawa, Y., and Konishi, Y., Induction of 8-hydroxydeoxyguanosine but not initiation of carcinogenesis by redox enzyme modulations with or without menadione in rat liver, Carcinogenesis, 12:719-726, 1991.
438. Ames, B. N., Measuring oxidative damage in humans: relation to cancer and aging, IARC Sci. Publ., 89:407-416, 1988.
439. Ames, B. N., Endogenous DNA damage as related to cancer and aging, Mutat. Res., 214:41-46, 1989.
440. Pitot, H. C., Beer, D. G., and Hendrich, S., Multistage carcinogenesis of the rat hepatocyte, in Banbury Report 25: Nongenotoxic Mechanisms in Carcinogenesis, Cold Spring Harbor Press, Cold Spring Harbor, 1987, pp. 41-51.
441. Pitot, H. C. and Dragan, Y. P., Facts and theories concerning the mechanism of carcinogenesis, FASEB J., 5:2280-2286, 1991.
442. Pitot, H. C., Altered hepatic foci: their role in murine hepatocarcinogenesis, Annu. Rev. Pharmacol. Toxicol., 39:465-500, 1990.
443. Garvey, L. K., Swenberg, J. A., Hamm, Jr., T. E., and Popp, J. A., Di(2-ethylhexyl)phthalate: lack of initiating activity in the liver of female F-344 rats, Carcinogenesis, 8:285-290, 1987.
444. Williams, G. M., Maruyama, H., and Tanaka, T., Lack of rapid initiating, promoting, or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver carcinogenesis, Carcinogenesis, 8:875-880, 1987.
445. Ward, J. M., Rice, J. M., Creasia, D., Lynch, P., and Riggs, C., Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice, Carcinogenesis, 4:1021-1029, 1983.
446. Ward, J. M., Diwan, B. A., Ohshima, M., Hu, H., Schuller, H. M., and Rice, J. M., Tumor-initiating and promoting activities of di(2-ethylhexyl)phthalate in vivo and in vitro, Environ. Health Perspect., 65:279-291, 1986.
447. Preat, V., Lans, M., de Gerlache, J., Taper, H., and Roberfroid, M., Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis, Jpn. J. Cancer Res., 77:629-638, 1986.
448. Cattley, R. C., Marsman, D. S. and Popp, J. A., Failure of the peroxisome proliferator WY-14,643 to initiate growth-selectable foci in rat liver, Toxicology, 56:1-7, 1989.
449. Glauert, H. P. and Clark, T. D., Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis, Cancer Lett., 43:95-100, 1989.
450. Popp, J. A., Garvey, L. K., Hamm, J. T. E., and Swenberg, J. A., Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate, Carcinogenesis, 6:141-144, 1985.
451. Oesterle, D. and Demi, E., Promoting activity of di(2-ethylhexyl)phthalate in rat liver foci bioassay, J. Cancer Res. Clin. Oncol., 114:133-136, 1988.
452. Maruyama, H., Tanaka, T., and Williams, G. M., Effects of the peroxisome proliferator di(2-ethylhexyl)-phthalate on enzymes in rat liver and on carcinogeninduced liver altered foci in comparison to the promoter phenobarbital, Toxicol. Pathol., 18:257-267, 1990.
453. Ward, J. M., Ohshima, M., Lynch, P., and Riggs, C., Di(2-ethylhexyl)phthalate but not phenobarbital promotes N-nitrosodiethylamine-initiated hepatocellular proliferative lesions after short-term exposure in male B6C3F1 mice, Cancer Lett., 24:49-55, 1984.
454. Hagiwara, A., Diwan, B. A., and Ward, J. M., Modifying effects of butylated hydroxyanisole, di(2-ethylhexyl)phthalate or indomethacin on mouse hepatocarcinogenesis initiated by N-nitrosodiethylamine, Jpn. J. Cancer Res., 77:1215-1221, 1986.
455. Ward, J. M., Konishi, N., and Diwan, B. A., Renal tubular cell or hepatocyte hyperplasia is not associated with tumor promotion by di(2-ethylhexyl)phthalate in B6C3F1 mice after transplacental initiation with N-nitrosoethylurea, Exp. Pathol., 40:125-138, 1990.
456. Reddy, J. K. and Rao, M. S., Enhancement of Wy14,643, a hepatic peroxisome proliferator of diethylnitrosamine-initiated hepatic tumorigenesis in the rat, Br. J. Cancer, 38:537-543, 1978.
457. Mochizuki, Y., Furukawa, K., and Sawada, N., Effects of various concentrations of ethyl-alpha-p-chlorophenoxy-isobutyrate (clofibrate) on diethylnitrosamine-induced hepatic tumorigenesis in the rat, Carcinogenesis, 3:1027-1029, 1982.
458. Glauert, H. P., Beer, D., Rao, M. S., Schwarz, M., Xu, Y., Goldworthy, T. L., Coloma, J., and Pitot, H. C., Induction of altered foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine, Cancer Res., 46:4601-4606, 1986.
459. Preat, V., de Gerlache, J., Lans, M., Taper, H., and Roberfroid, M., Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichlorethane, butylated hydroxytoluene, and nafenopin on rat hepatocarcinogenesis, Carcinogenesis, 7:1025-1028, 1986.
460. Preat, V. and Roberfroid, M., Modulation of rat hepatocarcinogenesis by peroxisome proliferators. Second International Conference on Anticarcinogenesis and Radiation Protection, Gaithersburg, MD, March 8-12, 1987.
461. Cattley, R. C. and Popp, J. A., Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver, Cancer Res., 49:3246-3251, 1989.
462. Hosokawa, S., Tatematsu, M., Aoki, T., Nakanowatari, J., Igarashi, T., and Ito, N., Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator, Carcinogenesis, 10:2237-2241, 1989.
463. Greaves, P., Irissari, E., and Monro, A. M., Hepatic foci of cellular alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility, J. Natl. Cancer Inst., 76:475-484, 1986.
464. Cattley, R. C., Marsman, D. S., and Popp, J. A., Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver, Carcinogenesis, 12:469-473, 1991.
465. Marsman, D. S. and Popp, J. A., Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy14,643, Carcinogenesis, 15:111-117, 1994.
466. Kurokawa, Y., Takamura, N., Matushima, Y., Imazawa, T., and Hayashi, Y., Promoting effect of peroxisome proliferators in two-stage rat renal tumorigenesis, Cancer Lett., 43:145-149, 1988.
467. Hagiwara, A., Tamano, S., Ogiso, T., Asakawa, E., and Fukushima, S., Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine, Jpn. J. Cancer Res., 81:1232-1238, 1990.
468. Fukushima, S., Hagiwara, A., Hirose, M., Yamaguchi, S., Tiwawech, D., and Ito, N., Modifying effects of various chemicals on preneoplastic lesion development in a wide-spectrum organcarcinogenesis model using F344 rats, Jpn. J. Cancer Res., 82:642-649, 1991.
469. Mitchell, F. E., Price, S. C., Grasso, P., Hinton, R. H., and Bridges, J. W., Effects of di(2-ethylhexyl)phthalate on male and female rats (abstract). Poster given at the International Conference on Phthalic Acid Esters, University of Surrey, August 6-7, 1984; Abstracts: 10.
470. Lington, A., Schneider, B., Moran, E., Stoltz, M., Windels, J., and El-hawari, M., Liver and lipid effects of diethylhexyl phthalate (DEHP) and diethylhexyl adipate (DEHA) in Fischer 344 rats, Toxicologist, 5:159, 1985.
471. Conway, G. C., Tomaszewski, K. E., Olson, M. J., Cattley, R. C., Marsman, D. S., and Popp, J. A., Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643, Carcinogenesis, 10:513-519, 1989.
472. Perera, M. I. R., Katyal, S. L., and Shinozuka, H., Suppression of choline-deficient diet-induced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-β-hydroxyethyl)acetamide and di(2-ethylhexyl)phthalate, Cancer Res., 46:3304-3308, 1986.
473. Perera, M. I. R., Betschart, J. M., Virji, M. A., Katyal, S. L., and Shinozuka. H., Free radical injury and liver tumor promotion, Toxicol. Pathol., 15:51-59, 1987.
474. Cohen, M., 1983, Briefing package on DEHP in children's products to the commissioners of the Product Safety Commission. Section III: Dose response assessment, Washington, D.C.: USCPSC, as cited in Beliles, R., Salinas, J. A., and Kluwe, W. M., A review of di(2-ethylhexyl)phthalate (DEHP) risk assessments, Drug Metab. Rev., 21:3-12, 1989.
475. Cohen, M., 1983, Briefing package on DEHP in children's products to the commissioners of the Product Safety Commission. Section III: Dose response assessment, Washington, D.C.: USCPSC, as cited in Beliles, R., Salinas, J. A., and Kluwe, W. M., A review of di(2-ethylhexyl)phthalate (DEHP) risk assessments, Drug Metab. Rev., 21:3-12, 1989.
476. NRC, National Research Council, Toxicity of selected toxicants: di(2-ethylhexyl)phthalate (DEHP) and mono(2-ethylhexyl)phthalate (MEHP), in Drinking Water and Health, Vol. 6, National Research Council, National Academy Press, Washington, D.C., 338-359 and 409-437, 1986.
477. EPA, U.S. Environmental Protection Agency, 1987, Draft; Health and Environmental Effects Profile for Phthalic Acid Alkyl, Aryl, and Alkyl/aryl Esters, Cincinnati, OH: USEPA, cited in Beliles, R., Salinas, J. A., and Kluwe, W. M., A review of di(2-ethylhexyl)-phthalate (DEHP) risk assessments, Drug Metab. Rev., 21:3-12, 1989.
478. EPA, U.S. Environmental Protection Agency, 1987, Draft; Health and Environmental Effects Profile for Phthalic Acid Alkyl, Aryl, and Alkyl/aryl Esters, Cincinnati, OH: USEPA, cited in Beliles, R., Salinas, J. A., and Kluwe, W. M., A review of di(2-ethylhexyl)-phthalate (DEHP) risk assessments, Drug Metab. Rev., 21:3-12, 1989.
479. EPA, U.S. Environmental Protection Agency, 1988, Draft; Drinking Water Criteria Document for Phthalic Acid Esters (PAEs), Cincinnati, OH: USEPA, cited in Beliles, R., Salinas, J. A., and Kluwe, W. M., A review of di(2-ethylhexyl)phthalate (DEHP) risk assessments, Drug Metab. Rev., 21:3-12, 1989.
480. EPA, U.S. Environmental Protection Agency, 1988, Draft; Drinking Water Criteria Document for Phthalic Acid Esters (PAEs), Cincinnati, OH: USEPA, cited in Beliles, R., Salinas, J. A., and Kluwe, W. M., A review of di(2-ethylhexyl)phthalate (DEHP) risk assessments, Drug Metab. Rev., 21:3-12, 1989.
481. IARC Monographs on the evaluation of carcinogenic risks to humans, 1987, Suppl. 7.
482. EPA, U.S. Environmental Protection Agency, 1986, cited in Schulz, C. O., Assessing human health risks from exposure to di(2-ethylhexyl)phthalate (DEHP) and related phthalates: scientific issues, Drug Metab. Rev., 21:111-120, 1989.
483. Committee of Principal Investigators, WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up, Lancet, 2:600-604, 1984.
484. Research Committee of the Scottish Society of Physicians, Ischaemic heart disease: a secondary prevention trial using clofibrate, Br. Med. J., 4:775-784, 1971.
485. The Coronary Drug Project Research Group, Clofibrate and niacin in coronary heart disease, J. Am. Med. Assoc., 231:360-381, 1975.
486. Saracci, R., Kogevinas, M., Bertazzi, P. A., Bueno de Mesquita, B. H., Coggon, D., Green, L. M., Kauppinen, T., Ka, L. A., Littorin, M., Lynge, E., et al., Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols [see comments], Lancet, 338:1027-1032, 1991.
487. Bueno de Mesquita, H. B., Doombos, G., Van der Kuip, D. A., Kogevinas, M., and Winkelmann, R., Occupational exposure to phenoxy herbicides and chlorophenols and cancer mortality in The Netherlands, Am. J. Ind. Med., 23:289-300, 1993.
488. Asp, S., Riihimäki, V., Hernberg, S., and Pukkala, E., Mortality and cancer morbidity of Finnish chlorophenoxy herbicide applicators: an 18-year prospective follow-up, Am. J. Ind. Med., 26:243-253, 1994.